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CHAPTER I 
 
INTRODUCTION 
 
All organisms are composed of cells. Every cell comes from a pre-existing cell (1). 
Each cell contains a set of instructions and the production facilities for making the 
materials that will form a new cell. The instructions are encoded in the sequence of DNA, 
which is the genetic information, and the totality of genetic information for a cell is called 
the genome. During cell proliferation, the genome has to be duplicated precisely, and two 
copies of the genome have to be evenly propagated into two daughter cells. Maintaining 
genome integrity is critical for cellular viability and disease prevention in multicellular 
organisms including humans.  
DNA is composed of two strands that twist together to form a helix and is packed 
into a set of chromosomes (2, 3). The DNA replication process is a semi-conservative 
process (4). Parental DNA strands are unwound and used as templates to synthesize 
complementary strands. As a result, each new copy of the DNA helix will have one 
strand of parental DNA and one nascent strand when DNA replication is finished. Cells 
are constantly challenged by DNA damaging agents from endogenous and exogenous 
sources. Free oxygen radicals, by-products of normal cellular metabolism, and ultraviolet 
radiation from environmental sources cause DNA lesions. The ability of cells to deal with 
DNA damage is essential for maintaining genome integrity. Damaged DNA will result in 
erroneous DNA replication if the damage is not corrected. The altered genetic 
information will be passed into daughter cells permanently after chromosome 
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propagation and cell division. When mutations arise, activation of oncogenes and 
inactivation of tumor suppressor genes can occur. This can promote more mutations. 
Accumulated mutations are a characteristic of tumors in humans.  
In this chapter, I will discuss how the DNA replication process is regulated in 
cells, how DNA damage causes problems during DNA replication, and how cells respond 
to these problems to maintain genome integrity. 
 
The Cell Cycle and DNA Replication 
Cell proliferation is a complex process that includes duplication of the cellular 
components and division into two cells. This process is called the cell cycle and can be 
separated into four different phases by functional purposes (Figure 1.1A). DNA 
replication occurs during S phase (DNA synthesis), and cell division occurs in M phase 
(mitosis). Two gap phases (G1 and G2) separate the S and the M phases. Cells prepare 
for DNA replication in G1 phase and prepare for cell division in G2 phase. 
 
Regulation of eukaryotic cell cycle 
Cell cycle progression is controlled by a series of cyclin-dependent kinases (Cdks) 
(5). Cdk activation requires their binding partners, cyclins. Cyclins are expressed in a 
cyclical fashion (6, 7). They have no catalytic activities. The expression of Cdks is not 
changed in different phases throughout the cell cycle. The oscillating expression of 
cyclins results in oscillating activities of Cdks by forming corresponding Cdk-cyclin 
complexes in different phases (Figure 1.1A). 
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Figure 1.1. Cdk activities control the cell cycle progression. (A) 
Cell cycle progression. The cell cycle consists of four phases, G1, S, 
G2, and M phases. Oscillating expressed cyclins activate 
correspondent Cdks for different phases. DNA replication occurs in S 
phase, and cell division occurs in M phase. Colors of cyclins 
correspond to different phases of the cell cycle. (B) Kinase activity of 
Cdk-cyclin is regulated through phosphorylation, one activatory 
phosphorylation (T161 on Cdk1) and one inhibitory phosphorylation 
(Y15 on Cdk1). 
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Cyclin D expression is stimulated in response to mitogenic factors in the 
extracellular environment in G1 phase (8). Cyclin D binds to Cdk4 or Cdk6. Cdk4/6-
cyclin D complexes phosphorylate the tumor suppressor protein Rb, which results in the 
release of transcription factors including E2F (9, 10). This promotes the expression of 
cyclin E (11, 12). Cyclin E associates with Cdk2 and activates Cdk2. Activation of the 
Cdk2-cyclin E complex drives cells entering S phase through phosphorylation of various 
targets including Rb (11, 13). Upon entry into S phase, cyclin E undergoes degradation 
mediated by the proteasome (14, 15). Cyclin A expression results from the activation of 
Cdk2-cyclin E. The activity of Cdk2-cyclin A drives cells through S phase and regulates 
DNA replication (3, 16). Cyclin A remains present throughout the G2 phase and 
associates with Cdk1 during the transition from G2 to M phase. Upon entry into M phase, 
cyclin A is degraded, and cyclin B associates with Cdk1 to drive cells through M phase 
(17).  
In addition to cyclins, the activities of Cdks can also be regulated by cellular 
inhibitors and phosphorylation. The inhibitors of Cdk4 proteins (INK4), p16, p15, p18, 
and p19, specifically bind to and inhibit Cdk4 and Cdk6 (18). The Cip/Kip family of 
proteins including p21 and p27 act as broad inhibitors for Cdk4, Cdk6, Cdk2, and Cdk1 
(19). Cdk2 and Cdk1 undergo two types of phosphorylation for activating and inhibiting 
their kinase activities (Figure 1.1B). Cdk2 phosphorylation on threonine 160 is required 
for activities of Cdk2-cyclin E and Cdk2-cyclin A and is accomplished through Cdk-
activating kinase (CAK) (20-22). Cdk2 is also phosphorylated on inhibitory sites, 
threonine 14 and tyrosine 15 (19, 20). The inhibitory phosphorylations are relieved by the 
action of the phosphatase Cdc25 (23). Cdk1 also undergoes similar positive and negative 
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regulations by phosphorylation. Both the phosphorylation of threonine 161 and 
dephosphorylation of threonine 14 and tyrosine 15 are required for Cdk1 activity (24). 
 
DNA replication 
While DNA replication occurs in S phase, the assembly of replication fork 
components starts in M phase. DNA replication starts from the region of DNA called 
replication origins, marked by origin recognition complexes (ORC) (25). In metazoans, 
DNA replication origins are less understood than in yeast, although a handful of origins 
has been mapped including the β-globin gene clusters (26). In G1 phase, ORC assembly 
promotes the pre-replication complex (PRC) formation on replication origins by 
recruiting Cdc6 and Cdt1 (25).  
The mini-chromosome maintenance (MCM) complex consists of six-subunits, 
Mcm2-7, and functions as a DNA helicase to unwind the parental DNA while the 
replication fork moves (25). The MCM complex is required for DNA replication 
initiation and elongation (27). The MCM complex is recruited to DNA through the 
coordination of Cdc6 and Cdt1 in G1 phase (28-30). The stabilization of MCM 
complexes on DNA is achieved by Cdc45 and GINS [Go, Ichi, Nii, and San; five (Sld5), 
one (Psf1), two (Psf2), and three (Psf3) in Japanese] complex (31-34).  
DNA replication elongation is carried out by many proteins, forming replication 
forks (Figure 1.2). DNA synthesis is accomplished by DNA polymerases starting from a 
primer with a direction from 5' end to 3' end (3, 35). Replication protein A (RPA) has a 
strong affinity for single stranded DNA (ss-DNA) (36). Parental DNA unwinding 
generates ss-DNA, and RPA is loaded onto the ss-DNA followed by the recruitment of  
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Figure 1.2. A simplified replication fork. MCM complex functions 
in unwinding parental double strand DNA. Polymerase α (α) 
generates RNA-DNA primers for DNA synthesis. Polymerase ε 
functions in leading strand thesis, and Polymerase δ functions in 
lagging strand synthesis. The leading strand synthesis is continuous, 
and the lagging strand synthesis is discontinuous with okazaki 
fragments synthesis. PCNA stabilizes polymerases on DNA. RPA 
binds to single strand DNA.  
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primase/polymerase α (pol α) (37). The primase forms an RNA primer followed by a 
short DNA primer to pair with the template DNA. DNA synthesis starts from the RNA-
DNA primer. The RNA-DNA primer synthesis promotes the loading of proliferating cell 
nuclear antigen (PCNA). PCNA functions in stabilizing DNA polymerase δ (Pol δ) and 
DNA polymerase ε (Pol ε) on DNA (25, 38, 39). Both Pol ε and Pol δ are high fidelity 
DNA polymerases for leading strand and lagging strand synthesis respectively. For 
leading strand synthesis, priming is only required once. Lagging strand synthesis is 
accomplished through the synthesis of okazaki fragments (35). 
 
Model systems used to study DNA replication  
Several model systems have been used to study the regulation of DNA replication. 
The budding yeast model system has several advantages for studying DNA replication. 
The replication origins are well defined and conserved from cell to cell (25). Genetic 
background manipulation is easier in yeast than in mammalian cells. The Xenopus egg 
extract system has also been used to study DNA replication as a model system (40). In 
this system, the concentrated S phase components support a robust DNA replication in 
vitro. A particular protein deficient background can be achieved by immuno-depletion 
with a specific antibody. Any region on DNA can serve as a replication origin. 
In mammalian cells, both SV40 and oriP episomes have been used to study DNA 
replication. The SV40 episome is derived from the simian virus. DNA replication on the 
SV40 episome starts from the SV40 origin in both directions. The SV40 episome 
replication bypasses the requirement for pre-replication complex formation (41). Large T 
antigen functions as a DNA helicase and binds to the SV40 origin (42, 43). This is 
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sufficient for replication initiation and elongation of SV40 episomes (41). Because of this 
unique characteristic, the SV40 episome can replicate constantly in S phase. Also, the 
SV40 episome can replicate in vitro with cell extracts from S phase, supplemented with 
the large T antigen protein (44, 45). The oriP episome is derived from the Epstein-Barr 
virus (EBV). Replication starts from the oriP origin in one specific direction (46). EBNA-
1 is the only viral protein required to support oriP episome replication in mammalian 
cells (47). EBNA-1 contributes to recruiting the ORC complex to the oriP origin, and 
then the DNA replication machinery is utilized to support episome replication (48, 49). 
This regulation limits the oriP episome replication to only once per cell cycle (50). 
 
Cellular Responses to DNA Damage 
The activities of DNA helicases and DNA polymerases are coordinated to 
function in replication fork progression. The DNA replication process is challenged by 
various DNA damaging agents from internal and external sources. Cells have evolved 
complex mechanisms including DNA repair, cell cycle checkpoint activation, senescence, 
and apoptosis to safeguard the precise duplication of DNA and to maintain genome 
integrity. 
 
DNA repair 
Damaged DNA can be repaired by different mechanisms according to the type of 
damage (51). Base excision repair (BER) continually acts to correct non-bulky damage to 
bases resulting from hydrolysis, oxygen free radicals, and simple alkylating agents or 
spontaneous loss of the DNA base itself (52). Activation of BER is independent of DNA 
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replication or transcription. The damaged base is removed by DNA glycosylase. The 
apurinic/apyrimidinic (AP) endonuclease then removes the abasic site by niching the 
DNA, and the gap is filled by DNA polymerase β and DNA ligase. This gap can be a 
single nucleotide (nt) or up to 13 nt in length (52). 
Nucleotide excision repair (NER) removes DNA lesions that often cause both a 
helical distortion of the DNA duplex and a modification of the DNA chemistry (53). The 
most significant of these lesions are pyrimidine dimers, cyclobutane pyrimidine dimers 
(CPDs) and (6-4) photoproducts (6-4PPs), two major kinds of DNA damage produced by 
the shortwave UV component of sunlight (54, 55). In addition, numerous bulky chemical 
adducts and DNA intra-strand cross-links are eliminated by this process (56). Although 
NER is not essential for viability, patients younger than 20 years with the inherited 
syndrome xeroderma pigmentosum (XP) have a roughly 1000-fold increased incidence of 
skin cancers (57). The XP gene products (XPA to XPG) are now known to perform 
various functions during damage recognition and DNA incision of NER (51). DNA 
endonucleases cleave the DNA strand with the lesion and generate a repair patch about 
25-30 nt long (51). RPA binds to and stabilizes the exposed ss-DNA. DNA polymerase δ 
and ε are required for DNA synthesis to fill this gap, and the gap is sealed by DNA ligase. 
Transcription can enhance NER efficiency when the damaged site falls in a 
transcriptionally active region. 
DNA double strand breaks (DSBs) can result from exogenous agents such as 
ionizing radiation (IR) and certain chemotherapeutic drugs including mitomycin C 
(MMC) and etoposide, from endogenously generated reactive oxygen species, and from 
mechanical stress on the chromosomes (58). Failure to rejoin breaks properly can lead to 
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loss of portions of chromosomes or chromosomal rearrangements. End-joining can be 
achieved through single strand annealing (SSA), non-homologous end joining (NHEJ), 
and homologous recombination (HR). SSA and NHEJ often result in the loss or gain of a 
few nucleotides (59). For the SSA repair pathway, the ends of DSB are resected to single 
strand DNA with 3' overhangs by exonucleases followed by Rad52 binding. Rad52 
facilitates the annealing of complementary single strand DNA at these termini (60). DSB 
ends also can be directly ligated through NHEJ. The Ku heterodimer, consisting of Ku70 
and Ku80, forms a complex with the DNA dependent protein kinase catalytic subunit 
(DNA-PKcs) and facilitates NHEJ repair (61, 62). During HR, a sister chromatid or a 
homologous chromosome is utilized as a repair template (63). Break ends are resected to 
single strand DNA with 3' overhangs. Rad52 binds to the single strand DNA filaments 
followed by the recruitment of Rad51. Rad51 directs a strand invasion into a homologous 
chromosome followed by DNA synthesis (63). Although HR is an error-free repair 
pathway for the DSB, it can result in loss of heterozygosity (LOH) (64). 
DNA inter-strand cross-links (ICL) are highly cytotoxic (65). ICL occurs when 
cells are treated with cancer therapy drugs including cisplatin. It is not well understood 
how ICL is repaired. It has been proposed that both NER and HR are involved in ICL 
repair (66). 
 
Cell cycle arrest 
Cell cycle progression has to be coordinated with DNA repair in order to 
safeguard genome stability (67). Cell cycle checkpoints function to halt cell cycle 
progression in a particular phase and provide more time for DNA repair before entering 
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the next phase (68). Cell cycle progression is regulated by oscillating Cdk activities. 
Arresting cell cycle progression is achieved through inhibition of Cdk activities. 
According to the different phases of the cell cycle, there are four cell cycle checkpoints, 
G1-S checkpoint, intra-S phase checkpoint, G2-M checkpoint, and spindle checkpoint 
(Figure 1.3). 
Replication of damaged DNA will cause genetic alteration. The G1-S checkpoint 
functions to arrest cells in the G1 phase and to allow cells to repair the damaged DNA. 
This arrest is achieved by inhibition of Cdk2 through induction of p21 and reduction of 
cyclin E (13). DNA damage induced signaling results in stabilization of p53 in the 
nucleus (69, 70). P53 is a transcription factor that stimulates the expression of p21, an 
inhibitor of Cdk2 (69, 71). When cell size is less than the threshold or when nutrient 
levels are reduced, Cdk4/6 activity is inhibited due to reduction of cyclin D expression. 
This results in suppression of Rb hyperphosphorylation. Hyperphosphorylation of Rb is 
required for releasing E2F, a transcription factor regulating gene expression for entering 
S phase including cyclin E (11, 12). 
While the function of the intra-S phase checkpoint is not well understood in 
humans, cells with a defective intra-S phase checkpoint exhibit radio-resistant DNA 
synthesis (RDS). In yeast, this checkpoint initiates at least three cellular actions (72). 
First, it slows DNA replication by inhibiting the initiation of additional replication origins. 
Second, it inhibits the onset of mitosis while replication is active. Third, it acts to resolve 
the problem at the stalled replication fork. Stabilization of stalled replication forks is the 
essential function of the intra-S phase checkpoint (73, 74). Intra-S phase checkpoint 
signaling is activated upon stalling of replication forks and results in rapid degradation of  
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Figure 1.3. Cell cycle checkpoints arrest the cell cycle progression. 
Cell cycle arrest is achieved by inhibition of Cdk-cyclin activities. DNA 
damage results in p53 stabilization, which stimulates p21 transcription. 
P21 inhibits the kinase activity of Cdks. Chk1 and Chk2 are activated 
upon checkpoint signaling. Then they phosphorylate Cdc25A and 
Cdc25C. Phosphorylation of Cdc25A leads to its rapid degradation. This 
functions as S phase checkpoint. P38 phosphorylates Cdc25B upon 
induction of DNA damage. Cdc25B and Cdc25C phosphorylation creates 
a binding site for 14-3-3, and this binding inhibits the phosphatase 
activity of Cdc25B and Cdc25C. Inhibition of Cdc25B functions in 
initiation of G2-M checkpoint, and inhibition of Cdc25C functions in 
maintenance of G2-M checkpoint. 
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Cdc25A (75, 76). Cdc25A removes the inhibitory phosphorylation of Cdks and is 
required for Cdk2 activity (77). Degradation of Cdc25A inhibits Cdk2 activity, which is 
required for the DNA replication process.  
 Prematurely entering mitosis with broken DNA or incompletely replicated DNA 
causes chromosome aberration in cells (3). The G2-M checkpoint functions to arrest cells 
in G2 phase through inhibition of Cdk1 activity (72). The G2-M checkpoint is initiated 
by p38 through phosphorylation of Cdc25B (78) and is maintained through 
phosphorylation of Cdc25C by Chk1 and Chk2 (77, 79, 80). Both phosphorylation of 
Cdc25B and Cdc25C facilitate their interaction with the protein 14-3-3, which inhibits 
the phosphatase activities of Cdc25B and Cdc25C (81, 82). Inactive Cdc25B and Cdc25C 
fail to remove the inhibitory phosphorylation of Cdk1, which results in inhibition of Cdk1 
(23). 
 Until all chromosomes are properly attached to the spindles, the spindle 
checkpoint blocks a cell from undergoing mitosis into anaphase by inhibiting the 
anaphase-promoting complex (APC) (83). To achieve proper segregation, the two 
kinetochores on the sister chromatids must be attached to the opposite spindle poles, and 
tension of spindles has to be generated. Only this pattern of attachment will ensure that 
each daughter cell receives one copy of the chromosome (83). 
 
Senescence and apoptosis 
Apoptosis is the process of programmed cell death (PCD) that may occur in 
multicellular organisms, and senescence is a state of irreversible cell growth arrest (3). 
Both senescence and apoptosis can prevent cell proliferation and be induced by telomere 
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shortening and accumulation of DNA damage through the p53 and Rb pathways (84). 
Premalignant cells acquire the heritable capacity to grow beyond normal cell growth and 
escape from the control of apoptosis and senescence. Once premalignant cells acquire the 
ability to invade their surrounding tissues, cancer is developed. 
 
DNA damage response is an anti-cancer barrier 
Genetic instability is a hallmark of most cancers (85). Cells sense DNA damage 
and facilitate DNA repair along with cell cycle arrest. Genetically unstable cells are 
eliminated by apoptosis. Activation of oncogenes and inactivation of tumor suppressor 
genes will allow cells to bypass senescence or apoptosis (86, 87). Therefore, the DNA 
damage response (DDR) acts as an anti-cancer barrier by fixing the problem or 
eliminating genetically unstable cells. Patients with many inheritable diseases resulting 
from DDR deficiency exhibit cancer predisposition syndromes (Table 1.1). 
The cell cycle checkpoint is also an inducible barrier against tumor progression. 
This is evidenced by the fact that markers of DSB and DSB-induced checkpoint signaling 
are present in many precancerous lesions before p53 mutations are acquired (88, 89). 
Furthermore, oncogene-induced senescence requires DSB induced checkpoint signaling 
(90, 91). This checkpoint signaling results from DNA replication stress, characterized by 
multiply fired replication origins and prematurely terminated replication forks (90, 91). 
Thus, premalignant cells are under the pressure of selection by DDR mediated 
senescence during tumor progression. Overcoming the effects of the DDR allows 
genetically unstable cells to continuously proliferate. 
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Table 1.1. Examples of DDR genes associated with human diseases. 
 
Disease Functional defect Genetic deficiency 
Fanconi anemia Cross-link repair, checkpoint 
signaling 
Fanconi Anemia 
complementation group 
genes 
 
Ataxia-telangiectasia DSB repair, checkpoint 
signaling 
ATM 
Xeroderma pigmentosum Nucleotide excision repair XPA-G 
Nijmegen breakage 
syndrome 
DSB repair, checkpoint 
signaling 
NBS1 
Li-Fraumeni Checkpoint signaling, 
apoptosis, senescence 
p53 heterozygosity, 
Chk2 
HNPCC (hereditary 
nonpolyposis colon cancer) 
Mismatch repair, checkpoint 
signaling 
MSH2/6, MLH1 
Early onset breast and 
ovarian cancer 
DNA repair, checkpoint 
signaling 
BRCA1, 2 
Blooms syndrome  DNA replication, DNA 
repair 
BLM 
Werner syndrome DNA replication, DNA 
repair 
WRN 
RIDDLE syndrome DSB repair, checkpoint 
signaling 
RNF168 
ATLD syndrome DNA repair, checkpoint 
signaling 
Mre11 
Seckel syndrome DNA replication, checkpoint 
signaling 
ATR 
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ATM and ATR signaling mediates the DNA Damage Response 
The DDR is a signal transduction pathway that coordinates DNA replication with 
DNA repair, cell cycle checkpoint, and apoptosis during cell cycle progression (Figure 
1.4). The major regulators of the DDR are the phosphoinositide 3-kinase related protein 
kinases (PIKKs) including ATM (ataxia-telangiectasia mutated) and ATR (ATM and 
Rad3 related) (92). 
Like DNA-PK, both ATM and ATR are protein kinases with a strong preference 
to phosphorylate serine or threonine residues followed by glutamine (S/TQ) (61, 92-94). 
ATM phosphorylates Chk2 (79, 95), and ATR phosphorylates Chk1 respectively (96, 97). 
ATM and ATR also phosphorylate many of the same substrates including p53 (98-103). 
Chk1 and Chk2 are protein kinases and can also phosphorylate some substrates of ATM 
and ATR including p53 (104-106). The substrates of ATM and ATR function in repairing 
damaged DNA, arresting the cell cycle, regulating transcription, and inducing senescence 
and apoptosis (68). 
 
ATM Signaling Pathway 
The ATM-dependent pathway primarily responds to double strand breaks (DSBs) 
(92). This pathway can be activated throughout the cell cycle. Ionizing radiation (IR) 
causes DSBs in cells (58). When cells are irradiated with IR, the Mre11-Rad50-NBS1 
(MRN) complex and ATM form intranuclear foci rapidly (107-110). Phosphorylation of 
histone variant H2AX (γH2AX) is a known marker of DNA damage (111-113). Co-
localization of γH2AX with the MRN complex and ATM suggests that the MRN 
complex and ATM are recruited to the damage sites (114). 
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Figure 1.4. ATM and ATR signaling mediates DNA damage 
response. ATR and ATM are major regulators to mediate DDR. 
Upon DNA damage, ATM and ATR signaling regulates cellular 
events, DNA repair, cell cycle arrest, apoptosis, and senescence 
to either correct the errors or eliminate cells.  
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The MRN complex is required for ATM activation. The Mre11-Rad50 complex 
forms a dimer at DSB sites through Mre11 (115, 116). This suggests that the Mre11-
Rad50 complex functions in tethering DNA break ends. MRN foci formation after DSB 
is independent of ATM (108). ATM foci formation and activation of ATM requires the 
MRN complex (117, 118). The C-terminal region of NBS1 is required for ATM 
recruitment to DSB sites (119). This suggests that the MRN complex functions upstream 
of ATM activation. Consistently, patients with mutated Mre11 (A-TLD) or Nbs1 (NBS) 
exhibit defective ATM activation in response to DSB (120). 
The MRN complex also functions downstream of ATM to facilitate ATM 
signaling. Nbs1 is phosphorylated by ATM on several sites including S343, and the 
S343A mutant of Nbs1 causes hypersensitivity of these cells to IR (121). Mre11 
possesses both endonuclease and exonuclease activities (122). However, the nuclease 
activity of Mre11 is not required for ATM signaling (123). 
Upon DSB induction, ATM undergoes autophosphorylation on several sites 
including S1981 in the FAT domain (124, 125). The phosphorylated ATM promotes a 
conformation change from inactive dimers to active monomers (124). ATM 
phosphorylates many substrates including Chk2, p53 and MDM2 (67, 98, 126-129). 
Chk2 is a protein kinase and can phosphorylate p53, Cdc25A, and Cdc25C (75, 77, 79, 
126, 130). Phosphorylation of p53 on S20 by Chk2 contributes to stabilization of p53 by 
inhibiting the interaction of p53 with MDM2, the negative regulator of p53 (126, 130). 
Phosphorylation of MDM2 by ATM stabilizes p53 in the nucleus (127). Phosphorylation 
of p53 on S15 by ATM enhances transactivation activity of p53 (98, 128, 129). ATM also 
phosphorylates other proteins to facilitate DSB repair including H2AX (67). H2AX is 
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phosphorylated at the DSB site, and the signal is then spread to adjacent regions at least 
10 kb in humans and about 50 kb in yeast (131, 132). 
 
ATR Signaling Pathway 
ATR is activated during every S-phase to regulate the firing of replication origins, 
to stabilize and repair damaged replication forks, and to prevent premature onset of 
mitosis (133, 134). ATR exhibits a similar organization of functional domains as ATM 
(Figure 1.5). Sequence homology between ATM and ATR is exclusive to the C-terminal 
half of the proteins, a region that includes their kinase domains (92). The ATR signaling 
pathway includes recognizing DNA damage, stimulating the kinase activity of ATR, and 
amplifying the checkpoint signaling (Figure 1.6). Briefly, two checkpoint complexes, 
ATR-ATRIP and 9-1-1 complexes recognize a specific DNA-protein structure with 
single strand DNA (ss-DNA), RPA, and a 5' DNA junction. This allows ATR activity to 
be stimulated by TopBP1. Several mechanisms exist to amplify the signal of ATR 
activation towards Chk1 phosphorylation. This pathway is conserved in yeast and 
humans (Table 1.2). 
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Figure 1.5. Functional domains of ATM and ATR. The PIKK recruitment 
domain (PRD) domain of ATM interacts with Mre11-Rad50 complex. The 
PRD domain of ATR interacts with TopBP1. The sizes of domains are not to 
scale.  
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Figure 1.6. A simplified model of ATR signaling pathway. Two 
checkpoint complexes, ATR-ATRIP and 9-1-1 complexes are 
loaded to an ATR activation structure with single strand DNA, 
RPA, and a 5′ DNA junction. The kinase activity of ATR is 
enhanced by TopBP1, which is concentrated by 9-1-1 complex at 
the sites of DNA damage. Several mechanisms exist to amplify the 
signal of ATR activation including Claspin (see text).  
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                   Table 1.2. Protein orthologs in ATR signaling pathway. 
Protein Function H. sapiens S. cerevisiae S. pombe 
PIKK kinase ATR Mec1 Rad3 
 ATRIP Ddc2 Rad26 
    
Effector kinase Chk1 Rad53 Chk1 
    
Clamp loader Rad17 
Rfc2-5 
Rad24 
Rfc2-5 
Rad17 
Rfc2-5 
    
9-1-1 clamp Rad9 Ddc1 Rad9 
 Rad1 Rad17 Rad1 
 Hus1 Mec3 Hus1 
    
Kinase activator TopBP1 Dpb11 Cut5 
    
Chk1 adaptor Claspin Mrc1 Mrc1 
    
Replication fork stabilizer Timeless Tof1 Swi1 
 Tipin Csm3 Swi3 
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Recognizing DNA damage 
ATR is activated in response to many types of DNA damage including DSB and 
replication stress. Two checkpoint complexes are required for ATR signaling, ATR-ATR 
interacting protein (ATRIP) and Rad9-Hus1-Rad1 (9-1-1) complexes (133). Loading of 
both complexes to DNA requires a DNA-protein structure with single strand DNA (ss-
DNA), Replication protein A (RPA), and a 5' DNA junction. In S. cerevisiae, artificially 
manipulated co-localization of Mec1ATR-Ddc2ATRIP and 9-1-1 checkpoint complexes on 
DNA can activate Mec1ATR signaling in the absence of DNA damage (135). 
A ss-DNA motif has been suggested as the primary signal for ATR localization 
(136, 137). This DNA motif can be generated during DNA replication and DNA repair 
(25, 133). It is suggested that ATR activation in unperturbed cells at a basal level is 
required to regulate normal DNA replication (134, 138). An enhanced level of ATR 
activation is induced in comparison to the basal level activation of ATR in response to 
replication stress. Replication stress can result from insufficient deoxyribonucleotide 
triphosphate (dNTPs) or inhibition of primase. Long stretches of ss-DNA is the signal for 
the enhanced activation of ATR (139, 140). This type of ATR activation will be 
discussed in this chapter. 
Replication stress and DNA lesions cause stalled replication forks, which can 
form long stretches of ss-DNA. The coordination of DNA helicase and DNA 
polymerases is required for replication fork progression (25). The MCM complex 
unwinds parental DNA while pol ε and pol δ synthesize the complementary strands. 
Stalled replication forks can be caused by stalling DNA helicases or stalling the DNA 
polymerases. For example, a DNA inter-strand cross-link will stall DNA helicase 
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movement, and an intra-strand cross-link will only stall DNA polymerase movement. 
Only the latter type of stalled forks will form long stretches of ss-DNA, resulting from 
continued unwinding of the parental DNA by MCM helicases (37, 139). 
It is unclear whether ATR is activated at different levels when a polymerase is 
stalled on the leading strand or the lagging strand. A lesion on the lagging strand might 
yield a small gap between two Okazaki fragments since re-priming naturally happens all 
the time. Indeed, the length of ss-DNA generated varies by stalling DNA polymerases on 
the leading strand and the lagging strand. It is reported that the lesion induced by 
ultraviolet radiation (UV) generates long stretches of ss-DNA of up to 3 kb when the 
lesion is on the leading strand and up to 400 bases pairs when the lesion is on the lagging 
strand (141). This suggests that a DNA lesion on the leading strand may cause higher 
levels of ATR activation than a DNA lesion on the lagging strand. 
RPA coats most of the ss-DNA in cells (36). RPA is a heterotrimer complex 
consisting of three subunits: RPA70, RPA32, and RPA14, and is essential for DNA 
replication and DNA repair of eukaryotic cells (142). RPA binds tightly to ss-DNA with 
a defined 5'→3' polarity (143-145) and an affinity of up to about 10-9–10-10 M (146). 
The ability of RPA binding to ss-DNA is carried out by 
oligonucleotide/oligosaccharide-binding fold (OB-fold) domains (36).  RPA70 contains 
four OB-fold domains, DBD-N, DBD-A, DBD-B, and DBD-C, and one OB-fold domain 
exists on RPA32 and RPA14 respectively. Four OB fold domains possess strong affinity 
(µM) to ss-DNA including three OB-fold domains on RPA70 (DBD-A, DBD-B, and 
DBD-C) and one OB-fold domain on RPA32 (DBD-D) (36, 147). In the 30 nucleotide 
binding mode, the DBD-A, DBD-B, DBD-C, and DBD-D bind to ss-DNA (Figure 1.7A). 
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Figure 1.7. Models of RPA binding to DNA and proteins. (A) An 
RPA molecule binds to a single strand DNA with 30 nucleotides. 
DBD-A, DBD-B, and DBD-C on RPA70, and DBD-D on RPA32, 
four OB-fold domains bind DNA directly. RPA14 hinge RPA70 and 
RPA32 together by linking the DBD-C and DBD-D domains. (B) 
Predicted electrostatic interactions between basic RPA70N basic 
residues K88 and R41 with ATRIP acidic residues D58 and D59 
[adapted from (151)].  
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The OB-fold domain on RPA14 does not bind DNA. Instead, it functions as a hinge 
between the DBD-C and the DBD-D domain (148). The RPA70N OB-fold domain has a 
relatively weak affinity (mM) to ss-DNA (36, 149, 150). Instead, it binds to many 
proteins including ATRIP and p53 (149, 151).  
RPA undergoes phosphorylation in an unperturbed cell cycle and also upon 
induction of DNA damage. RPA32 is phosphorylated in S and G2 phase in human and 
yeast cells with unknown functions (152). Both RPA70 and RPA32 are 
hyperphosphorylated in response to DNA damage and replication stress (153, 154). 
RPA70 hyperphosphorylation is conducted by ATR and Chk1 (154), and RPA32 
hyperphosphorylation is conducted by DNA-PK, ATR, and Chk1 in vitro (154, 155). 
Functional significance of hyperphosphorylation of RPA70 and RPA32 remains 
unknown. Hyperphosphorylation of RPA alters its affinity with ss-DNA in vitro (154, 
156). This suggests that it may function in changing the mode of RPA binding with ss-
DNA (36). 
RPA70N forms a basic cleft structure [Figure 1.7B and reference (149, 151). In S. 
cerevisiae, the Rfa1RPA70–t11 mutation causes a charge reversal mutation, K45E within 
this basic cleft (157). Localization of Ddc2ATRIP-MEC1ATR and 9-1-1 complex to DSB 
sites is impaired in cells with the Rfa1-t11 mutant (137, 158, 159). The interaction of 
RPA70N with ATRIP localizes ATR-ATRIP complex to DNA damage sites (151, 160). 
In addition to RPA coated ss-DNA, a 5' DNA junction rather than a 3' DNA 
junction is also required for ATR activation [Figure 1.8A and reference (140)]. The 9-1-1 
complex is preferentially loaded to DNA with a 5' DNA junction but not the 3' DNA 
junction (159, 161). RPA is critical for the loading (159, 161). The specific polarity of  
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Figure 1.8. A common ATR activation structure. (A) Illustration of a 5′ 
DNA junction and a 3′ DNA junction. (B) ATR activation structure is 
formed when replication fork is stalled by a lesion on leading strand (left 
panel) and lagging strand (right panel). (C) ATR activation structure can be 
formed from DSB ends resection (top panel), NER processing (middle 
panel), and telomere erosion (bottom panel). Adapted from (133). 
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RPA binding to ss-DNA may contribute to this 9-1-1 complex preferential loading. The 
DNA motif with a 5' DNA junction is generated during the priming process facilitated by 
primase for lagging strand synthesis during normal DNA replication (25). Therefore, a 
stalled replication fork induced by stalling the lagging strand synthesis is more likely to 
activate ATR than by stalling the leading strand synthesis. However, it is also possible 
that a re-priming process occurs downstream of a lesion on the leading strand. 
The ATR activating structure, including ss-DNA, RPA, and a 5' DNA junction, 
can also be generated during processing of DSB, NER, and telomere erosion [Figure 1.8B 
and reference (133)]. Both DSB and telomere erosion can activate ATR signaling (162). 
However, ss-DNA with only up to 30 nt is generated during NER. It is not clear whether 
this together with a 5' DNA junction is sufficient for ATR activation. 
 
ATR-ATRIP complex 
 ATRIP was identified as an ATR interacting protein (163). ATR and ATRIP form 
co-localized damage inducible foci (163). ATRIP constitutively interacts with ATR, and 
the stability of ATR and ATRIP are linked (163). This relationship between ATRIP and 
ATR is conserved in yeast. In S. pombe and S. cerevisiae, Rad26ATRIP interacts with 
Rad3ATR, and Ddc2ATRIP interacts with Mec1ATR (164-167). ATRIP can be considered an 
obligate subunit of the ATR kinase. Loss of ATRIP copies the phenotypes of loss of ATR 
and vice versa (163). ATRIP regulates ATR activation through several mechanisms 
including localization and kinase activity of ATR (Figure 1.9). 
 ATRIP interacts with ATR through the N terminal region of ATR and the C 
terminal region of ATRIP [Figure 1.9 and reference (160)]. The coiled-coil domain of 
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Figure 1.9. Functional domains of ATRIP. ATRIP N terminal 
region binds RPA. The coiled-coil domain of ATRIP is required for 
ATRIP oligomerization. ATR binding domain is in the C terminal 
region. Four phosphorylation sites are marked (S68, S72, S224, and 
S239). Phosphorylation of S68 and S72 is induced by DNA damage 
with unknown function. Phosphorylation of S224 and S239 are 
required for the maintenance of G2-M checkpoint.  
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ATRIP regulates ATRIP oligomerization, which contributes to stabilizing the ATR-
ATRIP complex and is required for ATR signaling (168). 
The localization of the ATR-ATRIP complex to DNA damage sites is achieved 
through the interaction between ATRIP and RPA (137). Biochemical studies indicate that 
ATRIP directly interacts with RPA through the evolutionarily conserved N-terminal 
region of ATRIP and the RPA70N OB-fold domain of RPA (160). Disruption of the 
interaction between ATRIP and RPA by deletion of the ATRIP N-terminal region greatly 
reduces the ability of both ATR and ATRIP to localize to DNA damage sites (160). This 
interaction is the major mechanism by which ATRIP interacts with RPA-ssDNA; 
although, some residual interaction exists when the N-terminal region of ATRIP is 
deleted (169). Although disruption of this interaction in yeast causes a defect in ATR 
signaling after MMS treatment (151), disruption of this interaction does not affect ATR 
signaling in human cells (160). It is possible that additional means of ATR-ATRIP 
localization are largely sufficient for ATR activation. Indeed, ATRIP localizes to DNA 
damage sites in the absence of RPA. In S. cerevisiae, a DNA-binding domain on 
Ddc2ATRIP promotes the localization of Mec1ATR-Ddc2ATRIP to DNA damage sites (170). 
In vitro, the ATR-ATRIP complex exhibits the ability to bind ss-DNA in the absence of 
RPA (171). 
In addition to ATRIP interaction with RPA, localization of ATRIP to sites of 
DNA damage is also regulated by ATR in a complex with ATRIP. ATRIP interaction 
with ATR is through the C terminal region of ATRIP (160). Deletion of this region does 
not alter ATRIP interaction with RPA, but impairs ATRIP localization to sites of DNA 
damage (160). Although no functional significance of ATRIP phosphorylation by ATR 
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has been reported, ATR kinase activity contributes to the ATRIP localization (163, 172, 
173). In S. pombe, the replication protein Cdc18Cdc6 directly interacts with Rad26ATRIP 
and is required for the recruitment of Rad3ATR-Rad26ATRIP to chromatin (174). 
 ATR is a protein kinase with similar organization of functional domains to ATM. 
Unlike ATM, no autophosphorylation sites have been reported on ATR. Four 
phosphorylation sites have been identified on ATRIP including S68, S72, S224, and S239 
(173, 175, 176). S68 and S72 are substrates of ATR and are phosphorylated upon DNA 
damage. Although it is suggested that phosphorylation of S68 and S72 is upstream of 
ATR activation (173), the functional significance is unclear. Because they fall in the 
region of the RPA interaction domain on ATRIP, they may contribute to the interaction 
between ATRIP and the basic cleft of RPA70N. This will be further discussed in chapter 
V. Both ATRIP S224 and S239 phosphorylation are required for ATR signaling. This 
will be discussed in more detail in chapter III. 
 
9-1-1 complex  
The 9-1-1 complex consists of three subunits, Rad9, Hus1 and Rad1 (177). This 
complex is evolutionarily conserved in yeast and humans (178, 179). The structure of the 
9-1-1 complex in yeast was predicted to resemble the structure of the DNA replication 
clamp, proliferating cell nuclear antigen (PCNA), by molecular modeling techniques 
[Figure 1.10A and reference (180-182)]. PCNA forms a homotrimer with a ring-shaped 
structure through the PCNA domains (183). Rad9, Hus1, and Rad1 have a PCNA domain 
in the N terminal region (180-182). The 9-1-1 complex forms a heterotrimer through the 
PCNA domains of Rad9, Hus1, and Rad1 (Figure 1.10B). 
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Figure 1.10. DNA replication clamp and checkpoint clamp. (A) PCNA has 
two PCNA domains. Rad9, Hus1, and Rad1 all have two PCNA domains. The 
matched colors indicate the regions interacted directly in the complex. (B) 
PCNA forms a homotrimer, and Rad9, Hus1, and Rad1 form a heterotrimer 
complex. (C) PCNA and 9-1-1 complex are loaded by clamp loaders Rfc1-
Rfc2-5 and Rad17-Rfc2-5 complexes respectively. PCNA complex is loaded 
onto a 3′ DNA junction, and 9-1-1 complex is loaded onto a 5′ DNA junction. 
Both loading requires RPA.  
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The 9-1-1 complex is constitutively formed in cells. Depletion of Hus1 or Rad1 
decrease the stability of the other two components of the 9-1-1 complex in cells (184). 
Genetic knockout of Hus1 or Rad9 in mice causes embryonic lethality (185, 186). Cells 
exhibit reduced clonogenicity when Rad1 is depleted (184). Moreover, loss of Rad9, 
Hus1, or Rad1 produces similar defects including ATR signaling and sensitivities to 
genotoxic agents (184, 185, 187). This suggests that components of the 9-1-1 complex 
function together as a whole protein like the ATR-ATRIP complex.  
Both PCNA and the 9-1-1 complex are loaded onto DNA by clamp loaders 
(Figure 1.10C). The PCNA complex is loaded onto DNA by the replication factor C 
(RFC) complex, which consists of a large subunit, Rfc1 (p140), and four small subunits, 
Rfc2-5 (p40, p38, p37, p36) (188, 189). 9-1-1 complex loading onto DNA is carried out 
by the Rad17-Rfc2-5 complex (161, 190-194). Compared to the PCNA clamp loader, the 
Rfc1 subunit is replaced by Rad17 in this complex. The Rad17-Rfc2-5 complex interacts 
with the 9-1-1 complex and directly loads the 9-1-1 complex on DNA in an ATP 
dependent manner (190).  
PCNA is preferentially loaded onto the 3'-DNA junction in an ATP hydrolysis 
dependent manner [Figure 1.10C and reference (161)]. In contrast, the 9-1-1 complex is 
preferentially loaded onto the 5'-DNA junction (159, 161). Both PCNA and 9-1-1 
complex loading require RPA (161). In S. cerevisiae, Rfa1RPA70 can bind directly to Rfc4 
(195), and the rfa1-t11 mutant exhibits less efficiency than wild type Rfa1 to load the 
yeast 9-1-1 complex on DNA in vitro (159). RPA can directly load the Rad17-Rfc2-5 
complex onto DNA (196). It is unclear whether RPA interacts with PCNA or the 9-1-1 
complex directly. 
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It is also reported that topoisomerase-II-binding protein 1 (TopBP1) is required 
for 9-1-1 complex loading to DNA (197). In this study, depletion of TopBP1 inhibits 
primase, Rad17, and 9-1-1 complex loading in the Xenopus egg extract system. TopBP1 
is required for the chromatin loading of DNA polymerases and Cdc45 in replication 
initiation but is not required for DNA replication elongation (198-200). Therefore, the 
requirement of TopBP1 to load the 9-1-1 complex is distinct from TopBP1 function in 
replication initiation. The mechanism of TopBP1 recruitment to sites of DNA damage 
before 9-1-1 complex loading remains unknown. 
Similar to PCNA, the 9-1-1 complex can stimulate the activity of flap 
endonuclease 1 (FEN1), cleaving the RNA on the RNA-DNA primer generated by 
primase (201). This suggests that the 9-1-1 complex may function to generate a 
preferential loading site prior to its loading. However, it is unclear whether the 5'-
RNA/DNA junction is able to activate ATR as the 5'-DNA junction. 
Rad9, Hus1, and Rad1 are phosphorylated upon induction of DNA damage. 
Phosphorylation of Rad1 and Hus1 occurs in an ATR and TopBP1 dependent manner, 
but the functional significance remains unknown (202). The C-terminal tail of Rad9 
undergoes phosphorylation on at least nine serine or threonine sites [Figure 1.11 and 
reference (203, 204)]. Rad9 is loaded upon induction of DNA damage, and the Rad9 
mutant with all nine phosphorylation sites to alanine can be efficiently loaded onto DNA 
as wild type (205). Rad9 S272 site indicates a favorable substrate of ATM/ATR and is 
phosphorylated upon induction of DNA damage (205). The phosphorylation sites of Rad9, 
S277, S328, S336, and T355, are candidate substrates of Cdk (204). Rad9 
phosphorylation on S387 occurs constitutively (204). This is the only Rad9 
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Figure 1.11. Functional domains of Rad9. Rad9 has two PCNA domains 
and a unique C terminal tail compared to Rad1 and Hus1. A BH3 like 
domain on the very N terminal region interacts with BCL-2 and BCL-xL 
(top panel). This BH3 like domain of Rad9 is required for apoptosis 
induced by over-expression of Rad9. Phosphorylation of Rad9 on S160 is 
required for MMR function of Rad9, and phosphorylation of T225 is 
required for Rad9-mediated translesion synthesis. The C terminus tail of 
Rad9 contains nine phosphorylation sites and an NLS signal (bottom 
panel). Phosphorylation of S272 is induced by DNA damage, and S272 is a 
favorable substrate of ATM and ATR. Phosphorylation of S387 is required 
for Rad9 interaction with TopBP1. Deletion of the C terminus tail of Rad9 
does not affect the 9-1-1 complex formation. 
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phosphorylation site on the tail of Rad9 with known functional significance. 
Phosphorylation of Rad9 on S387 functions in concentrating TopBP1 at the DNA 
damage site through direct interaction with TopBP1 and is required for ATR signaling 
(203, 206). The Rad9 mutant, with all other phosphorylation sites in the C terminal tail 
mutated except S387, functions normally as wild type Rad9 in ATR signaling (203). 
Rad9 contains a nuclear localization signal (NLS) on the C-terminal tail (Figure 
1.11). The NLS domain of Rad9 is required for 9-1-1 complex nuclear localization, but 
deletion of the NLS domain of Rad9 does not affect Rad9 forming a complex with Hus1 
and Rad1 (207). The PCNA domains of Rad9 are involved in 9-1-1 complex formation. 
Over-expression of the PCNA domains of Rad9 induces apoptosis (207). Over-
expression of Rad9 induces apoptosis by antagonizing the anti-apoptotic activities of Bcl-
2 family proteins, BCL-2 and BCL-xL (208). Both BCL-2 and BCL-xL contain a BH-3 
domain (BCL-2 homology domain 3) (208). Rad9 also contains a BH3-like domain in the 
N terminal region (Figure 1.11). This BH-3 like domain of Rad9 regulates its localization 
to the nuclear envelope through interaction with BCL-2 and BCL-xL after MMS 
treatment (208). It is unclear whether the apoptosis induced by over-expression of Rad9 
requires the other two components of the 9-1-1 complex, Hus1 and Rad1. 
Loss of Rad9 causes hypersensitivity to IR, and this sensitivity can be inhibited by 
the Rad9 mutant, which is defective in checkpoint signaling (205). This suggests that the 
9-1-1 complex may play a role in DSB repair. Moreover, Rad9 and Rad1 exhibit 3' to 5' 
exonuclease activity, which indicates that Rad9 can process DSB ends to 3' overhangs 
(209, 210). In S. cerevisiae, the 9-1-1 complex is required for Ddc2ATRIP-Mec1ATR 
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localization to HO endonuclease-mediated but not IR induced DSB site in G1 (211). This 
further supports that 9-1-1 complex contributes to the processing of DSB ends. 
The 9-1-1 complex plays a role in BER and DNA translesion synthesis (TLS). 
Thymine DNA glycosylase (TDG) is a key DNA glycosylase that recognizes a wide 
array of DNA lesions, and FEN1 removes the displaced flaps generated by long-patch 
BER (52). The 9-1-1 complex interacts with TDG, and the interaction is enhanced with 
N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) treatment (212). The activity of TDG 
can be stimulated by Hus1, Rad1, and Rad9 separately, and also by the 9-1-1 complex in 
vitro (212). The 9-1-1 complex also can stimulate the activity of FEN1 in vitro (201). The 
9-1-1 complex can interact with DNA polymerase β and enhance its lesion bypass 
activity (213). In S. cerevisiae, the 9-1-1 complex is required for UV-induced 
mutagenesis, which requires the bypass TLS polymerase, polymerase ζ (214). In S. 
pombe, Rad9 interacts with the bypass polymerase, polymerase к (215). Phosphorylation 
of Rad9 on T225 is required for this interaction, which functions in loading polymerase к 
onto DNA (215). 
Rad9 also plays a role in mismatch repair (MMR) independent of Hus1 and Rad1 
(216). MLH1, a protein involved in mismatch repair, has been shown to interact with 
Rad9 (216). The minimum requirement of Rad9 for the interaction is the region 
containing residues 130 to 270 (216). Loss of Rad9 or the Rad9 mutant with S160 to 
alanine compromise MMR activity (216). However, this function of Rad9 is not required 
for the function of Rad9 in checkpoint signaling (216). 
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TopBP1 
TopBP1 functions in checkpoint signaling in addition to its function in replication 
initiation. TopBP1 contains eight BRCT (BRCA1 C-terminal domain) domains. The 
region between the 6th and the 7th BRCT repeats of TopBP1 was named ATR activation 
domain (AAD) (217). This domain enhances ATR kinase activity in vitro and is required 
for ATR signaling in vivo (217, 218). TopBP1 interacts with the ATR-ATRIP complex 
(217). Disruption of the interaction of TopBP1 with the ATR-ATRIP complex by 
mutation of ATRIP or ATR does not disrupt the ATR-ATRIP complex, but severely 
suppresses the stimulation of ATR kinase activity (218). The 1st and 2nd BRCT domains 
of TopBP1 interact with Rad9, and this interaction concentrates TopBP1 to damage sites 
for ATR activation (203, 206). 
 
Chk1 
Chk1 is an effector protein of ATR signaling (97, 219). Chk1 is phosphorylated 
by ATR on S345 and S317  (97, 220, 221). Chk1 phosphorylation occurs at the DNA 
damage site, and phosphorylated Chk1 dissociates from chromatin and diffuses in the 
nucleus to facilitate checkpoint signaling (222). Phosphorylation of Chk1 activates kinase 
activity of Chk1 towards Cdc25C on S216 (80). Phosphorylation of Cdc25C on S216 
creates a binding site for  the protein 14-3-3, which inhibits phosphatase activities of 
Cdc25C (80, 82). Inhibition of Cdc25C regulates the G2-M checkpoint as discussed 
previously. Chk1 also phosphorylates Cdc25A and promotes its degradation (76). This 
rapid destruction of Cdc25A inhibits Cdk2 activity and functions as an intra-S phase 
checkpoint (76). Similar to Chk2, Chk1 can phosphorylate p53, which results in 
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stabilization of p53 (106). This stabilization induces transcription of p21, which inhibits 
Cdk2 activity and cell cycle progression (69, 71). Thus, ATR activation arrests cell cycle 
progression through multiple mechanisms. 
Chk1 phosphorylation by ATR is regulated by several signal amplification 
mechanisms. Phosphorylation of Chk1 by ATR requires Claspin, which functions as an 
adapter protein to bring Chk1 to ATR (223). It is unclear whether Claspin is required for 
phosphorylation of other ATR substrates besides Chk1 (224). Claspin is phosphorylated 
by Chk1 in response to replication stress, and this phosphorylation promotes Claspin 
interaction with Chk1 (225, 226). This is one mechanism of signal amplification. Claspin 
is found at the replication fork (223). Claspin interacts with phosphorylated Rad17, and 
this interaction is required for sustained Chk1 phosphorylation (227). Rad17 
phosphorylation is ATR dependent (228). This may provide another mechanism for 
signal amplification. The Timeless-Tipin complex mediates Chk1 activation and the 
intra-S-phase checkpoint (229). Depletion of Timeless or Tipin decreases Chk1 
phosphorylation after DNA damage and replication stress. The Timeless-Tipin complex 
interacts with Claspin and RPA (229). This may be a third mechanism for signal 
amplification. 
 
Cross-Talk between ATM and ATR Pathways 
While ATM is not essential for cell viability, people with mutations in both alleles 
of ATM exhibit the neurodegenerative and cancer predisposition disorder ataxia-
telangiectasia (230). ATR is essential for cell viability (163, 231, 232). ATR mutations 
 40 
are rare and probably are only compatible with viability when cells have heterozygous or 
hypomorphic ATR.  
ATR forms intranuclear foci when cells are treated with IR (103, 160). Chk1 is 
phosphorylated when DSBs are induced in cells (233, 234). This ATR activation upon 
DSB induction is dependent on ATM (233-236). It is suggested that the resection of DSB 
ends is the signal to trigger ATR activation (133, 237, 238). DSB ends can be resected 
into 3'-overhangs by 5'-to-3' exonucleases including Exo1 and BLM in yeast and humans 
(239, 240). Although Mre11 nuclease activity is not required for ATM activation in 
response to DSB, it is required for ATR activation (233, 234, 240). ATM dependent DSB 
end resection results in the ATR activation structure, a DNA-protein motif with long 
stretches of ss-DNA, RPA, and 5' DNA junction. Moreover, TopBP1 S1131 is 
phosphorylated by ATM, and this phosphorylation is required for ATR activation in 
Xenopus egg extract system in response to DSB (241). Thus, ATR activation requires 
ATM activation in response to DSB. 
Replication stress results in stalled replication forks, which can activate ATR. The 
stalled forks can also result in DSBs (Figure 1.12). This is evidenced by γ-H2AX foci 
formation (242). However, induction of DSB is not the only signal to trigger ATM 
activation. One study suggests that ATM phosphorylation on S1981 is dependent on the 
kinase activity of ATR but not ATM (242). Moreover, this ATM activation is 
independent of the MRN complex (242). The ATM specific substrate Chk2 and the ATR 
specific substrate Chk1 function to regulate the G2-M checkpoint after replication stress 
(242). Thus, ATM and ATR cooperatively function to maintain genomic stability. 
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Figure 1.12. A stalled replication fork can be converted 
to a DSB. Replication fork stalling can form long stretches 
of single strand DNA, which can be attacked by DNA 
nuclease. This results in DSB.                    
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ATR Signaling and Cancer 
Mutations in many DDR genes lead to inherited diseases including 
neurodegenerative disorders, premature aging syndromes, and cancer predisposition 
syndromes (87). Hypomorphic mutations in ATR have been linked to rare cases of Seckel 
syndrome (67). These patients exhibit microcephaly and developmental defects (67). 
Seckel syndrome is the only disease that has been linked to mutations in proteins 
functioning in ATR signaling including Chk1, Claspin, and the 9-1-1 complex. This may 
be due to the fact that these proteins are essential for cellular viability (163, 185, 231). 
Therefore, these proteins are possible therapeutic targets for drug design to inhibit cell 
growth. 
Cell cycle progression is regulated by Cdks and monitored by cell cycle 
checkpoints (5, 68, 87). Two of the major cell cycle checkpoints are the G1-S checkpoint 
and the G2-M checkpoint (92). The ATR-Chk1 pathway is a major player for regulating 
the G2-M checkpoint (133). In p53-defective cells, the ATR-Chk1 pathway is even more 
important for cell survival from treatments of replication stress or DNA damage than in 
p53 proficient cells (243). Inhibition of ATR signaling selectively sensitizes G1-S 
checkpoint deficient cells to replication inhibitors or DNA damage (243). This suggests 
that some cancer cells are under selection for high dependency on the ATR-Chk1 
pathway to survive during tumorigenesis. Consistently, Rad9, Hus1, and Rad17 are 
required for ATR signaling (244), and increased expression of them has been seen in 
cancer cells (210, 245, 246). Depletion of Hus1 sensitizes non-small lung cancer cells to 
cisplatin (247). Therefore, proteins functioning in the ATR-Chk1 pathway can be good 
targets for designing therapeutic drugs, which are expected to selectively kill cancer cells.  
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Understanding how ATR Signaling is Regulated 
 Maintenance of high fidelity DNA replication and genome stability is essential for 
cellular viability and disease prevention. The process of cell proliferation is constantly 
challenged by many types of DNA damaging agents. ATR is activated in response to 
replication stress and DNA damage during every S phase (133). It mediates cell cycle 
checkpoint activation to coordinate with cell cycle progress and also stabilizes stalled 
replication forks.  
 The ATR-Chk1 pathway functions in stabilizing the stalled replication forks in 
yeast (248, 249). How does the ATR signaling pathway stabilize the replication forks? To 
answer this question, the first step is to identify the proteins on stalled replication forks. 
A system in which replication forks can be stalled at defined sites is needed. In chapter II, 
I establish a system in which a replication fork is stalled at a defined site. I attempt to 
detect proteins recruited to the stalled fork with this system.  
 How is ATR activation regulated? Many mechanisms by which ATRIP regulates 
ATR activation are already known. In chapter III, ATR activation regulated by a post-
translational modification on ATRIP and a novel ATRIP interacting protein is discussed. 
In chapter IV, I characterize the RPA70N domain that interacts with multiple checkpoint 
proteins including ATRIP, Mre11, and Rad9. I characterize the interaction between Rad9 
and RPA70N required for ATR signaling. 
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CHAPTER II 
 
STALLING A REPLICATION FORK AT A DEFINED SITE 
 
Summary 
Genetic instability is one characteristic of cancer cells. Genomic DNA has to be 
duplicated faithfully before cell division during cell proliferation. The DNA replication 
process constantly experiences endogenous and exogenous challenges. One consequence 
of replication stress is replication fork stalling. We hypothesized that proteins are 
recruited to the stalled replication forks to sense DNA damage and activate cell cycle 
checkpoints, stabilize the replication forks, and repair the damaged DNA to promote 
replication resumption. Currently, protein localization to sites of DNA damage is 
detected by immunofluorescence microcopy. Here I established a model system to detect 
protein localization by CHIP. In this system, a single replication fork is stalled at a 
defined site on an episome. Modifying this system and making it useful to study protein 
recruitments to the stalled replication forks are to be continued. 
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Introduction 
High fidelity DNA replication is essential for maintaining genome stability and 
preventing diseases (250, 251). During cell proliferation, genomic DNA is constantly 
exposed to varieties of DNA mutagens from endogenous and exogenous sources. The 
damaged DNA has to be repaired before cell division. Otherwise, permanent mutations 
on DNA will be generated and accumulated. Cell cycle checkpoints function in sensing 
these damages and arresting the cell cycle to allow more time for cells to repair the 
damaged DNA or inducing apoptosis or senescence to eliminate genetic unstable cells. 
The faithful duplication of the genome is a complex process involving multiple 
enzymatic activities that must be coordinated. DNA pre-replication complexes and 
replication initiation complexes only assemble once per cell cycle, and disassemble after 
DNA replication initiation to prevent DNA re-replication (25). In eukaryotic cells, 
replication forks can be stalled by many causes. DNA lesion can block DNA helicases 
and polymerases from moving along the DNA templates. Replication fork movement is 
impeded when replication occurs in the heterochromatin region. DNA polymerase and 
RNA polymerase collisions also impede replication fork movement. Since the pre-
replication complexes can not be re-assembled, stabilization of the stalled DNA 
replication forks is essential for the replication resumption (252). 
In yeast, Mec1ATR-Rad53Chk1 signaling pathway is required for cells recovery 
from replication stress or methyl methanesulphonate (MMS) treatment accompanied with 
accumulated unusual DNA structure at replication forks and high rates of irreversible 
fork collapse (248, 249). Currently very little is known about what happens at the stalled 
replication forks and how cell cycle checkpoints act to promote the recovery of fork 
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stalling in mammalian cells. Many proteins have been shown to form foci on sites of 
DNA damage and stalled replication forks including ATR and ATRIP detected by 
immunofluorescence microscopy (160, 163). The details of protein localization on the 
stalled forks are unclear due to the limitation of resolution with immunofluorescence 
microscopy technique. 
The chromatin immunoprecipitation (CHIP) method provides a higher resolution 
than immunofluorescence to study protein localizations on DNA. The finest resolution of 
an optical microscope is about 0.2 µm (3). CHIP is a PCR-based approach to analyze 
DNA interaction with protein. An extended 100 bp DNA is 0.034 µm in length (3). In 
addition, CHIP is a more sensitive approach than immunofluorescence because PCR is 
used to amplify the DNA fragments bound by proteins. To utilize CHIP to detect protein 
interaction with DNA, the information of DNA sequence is needed for PCR. Therefore, a 
model system with stalled replication forks at defined sites is needed. 
The model system of a single double strand break (DSB) at a defined site has 
been used successfully in yeast and mammalian cells to study cellular responses to DSBs. 
In yeast, the HO mating-type switch endonuclease cleaves a specific DNA sequence site 
on the genome (253). With this system, the kinetics of the protein recruitment to the DSB 
site were investigated (117, 254, 255). Recently, a single DSB was generated in 
mammalian cells to study protein recruitments to the DSB site by CHIP (131). We 
intended to establish a model system with a single replication fork stalling at a defined 
site similar to the above systems and expected that the CHIP would provide a high 
resolution and focused method to investigate the biologic events on stalled replication 
forks. 
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A DNA replication fork could be stalled at a defined site by inhibiting the 
separation of two strands of DNA templates. This inhibition of DNA strand separation 
can be achieved by cross-linking agents. It would be necessary to generate an inducible 
cross-link on the DNA if the chromosomal DNA was the cross-link target. Otherwise 
cells would either die or repair the cross-link to survive. Two model systems have been 
used to study the regulation of DNA replication in mammalian cells, SV40 and oriP 
episomes. The SV40 episome is derived from the simian virus, and the oriP episome is 
derived from the Epstein-Barr virus (EBV). Both SV40 and oriP episomes are convenient 
model systems to study DNA replication. The SV40 episome contains a bidirectional 
replication origin and bypasses the requirements of pre-replication complexes (41). The 
large T antigen (a viral protein) functions in DNA unwinding as the DNA replication 
helicases (41, 256). The oriP episome contains a unidirectional origin and utilizes all 
mammalian DNA replication machinery proteins in addition to EBNA-1, a viral protein 
to regulate episome replication (48, 49). It replicates once per cell cycle as does the 
mammalian genomic DNA (50). Thus these two episomes provide suitable vectors to 
generate a stalled replication fork.  
Several oligonucleotides form a triple helix with a sequence-specific double 
stranded DNA (257, 258). Therefore, psoralen can be conjugated on the oligonucleotide 
to induce a site-specific cross-link (257). In this study, I established an episome-based 
model system with a single stalled replication fork at a defined site. Modifying this 
system to make it useful to study protein recruitment to the stalled replication forks is to 
be continued. 
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Materials and Methods 
Cell culture, cell lines, and transfections  
HeLa and COS-1 cell lines were grown in DMEM (Invitrogen) supplemented 
with 7.5% fetal bovine serum at 37°C in 5% CO2. The HeLa cell line expressing the EBV 
viral protein EBNA-1 was established by retrovirus infection followed by G418 selection. 
Plasmid DNA transfections into HeLa cells were done with LipofectAMINE (Invitrogen). 
DNA transfections into COS-1 cells were done with Fugene 6 (Roche Applied Science) 
according to the manufacturer’s instructions.  
 
DNA constructs and oligonucleotides  
Oligonucleotides for the TFO target and the APRT target were synthesized 
(Invitrogen) and annealed. The TFO target and the APRT target were cloned into oriP 
and SV40 plasmid vectors (Table 2.1). pXX2, pXX3, pXX27, and pXX28 are oriP 
episomes generated with pCEP4 vector (Invitrogen) as the backbone. pXX2: a stop codon 
was generated on the N terminal region of EBNA-1; the TFO target was inserted; the 
furan ring of psoralen-TFO can be cross-linked on the leading strand. pXX3: same as 
pXX3 except the TFO target was inserted with the opposite direction; the furan ring of 
psoralen-TFO can be cross-linked on the lagging strand. pXX27: same as pXX2 except 
the EBNA-1 gene is intact. pXX28: same as pXX3 except the EBNA-1 gene is intact. 
pXX15: the oriP origin was deleted from pXX2. pXX23, pXX60, and pXX61 are SV40 
episomes generated with pcDNA3.1 vector (Invitrogen) as the backbone. The SV40 
derived plasmid including pXX23 (the TFO target was inserted; the furan ring of 
psoralen-TFO can be cross-linked on the leading strand), pXX60 (two APRT targets were 
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inserted; the TFO target was inserted; the furan ring of psoralen-TFO can be cross-linked 
on the leading strand), and pXX61 (two APRT targets were inserted; the TFO target was 
inserted; the furan ring of psoralen-TFO can be cross-linked on the lagging strand) were 
cloned with pcDNA3.1 vector (Invitrogen) as the backbone. 
The oligonucleotides of pso-TFO [5'-X1TTTTX2TTTTGGGGGGX3 (X1=psoralen 
C-6; X2=5-Me-dC; X3=C7 amine)] and pso-APRT [5'-
X1TGTGGTGGGGGGTTTGGGGX2 (X1=5' psoralen C-6; X2=C3 spacer)] were 
purchased from Oligo Etc., Inc. The primers of pCEP4 PPT 1F (5'-
ACCCCTCCTCTTCCTCTTCA) and pCEP4 PPT 1R (5'-
TGCCACCTGACGTCTAAGAA) were purchased from Invitrogen. 
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Table 2.1. A summary of constructs used in chapter II. 
 
(*TFO cross-link specificity is defined by the strand cross-linked with the furan ring of 
psoralen.) 
Construct Origin of episome 
TFO cross-link 
specificity* Other modifications 
pXX2 oriP Leading strand Transcription stop codon is inserted in 
EBNA-1 
pXX3 oriP Lagging strand Same as pXX2 
pXX27 oriP Leading strand EBNA-1 is intact compared to pXX2 
pXX28 oriP Lagging strand EBNA-1 is intact compared to pXX2 
pXX15 none Leading strand Same as pXX2 
pXX23 SV40 Leading strand  
pXX60 SV40 Leading strand Two APRT target inserted 
pXX61 SV40 Lagging strand Two APRT target inserted 
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Triple helix formation and cross-link induction  
Plasmid DNA 0.04 µM was incubated with 8 µM of pso-TFO in the TFM buffer I 
(10 mM Tris, pH 7.0, 50 mM NaCl, 10 mM MgCl2, 1 mM EDTA) at 37°C for 16 hours 
in the dark. DNA was precipitated with NH4Ac and ethanol and resuspended in TFM 
buffer I to achieve a concentration of 100 ng/µl) immediately followed by exposure to 1.8 
J/m2 UVA (365 nm) irradiation (Stratagene; split the DNA into 10 µl per drop on a piece 
of parafilm) or 400 nm light generated from a 150 W Xenon lamp at 37°C for 10 minutes 
[Rapid-Scanning Monochromator On-line Instrument System Inc., Olis Rsm 1000, 150 
W Xenon lamp with output 140 W, 6.32 slits (40 nm band pass), 400±20 nm wavelength 
light will pass the slits]. I thank Dr. Frederick Guengerich for letting me use the machine 
and Dr. Emre Isin for helping me set up the machine. The psoralen-APRT 
oligonucleotide directed triple helix formation was performed the same as the pso-TFO 
directed triple helix formation except the TFM buffer II (10 mM Tris, pH 7.6, 10 mM 
MgCl2, 10% glycerol) was used.  
 
Determine cross-linking efficiency 
DraI protection assay was performed to determine the inter-strand cross-linking 
efficiency. DNA was digested with DraI and then separated on 3.5% polyacrylamide gel 
in 1xTBE. The gel was stained with ethidium bromide and imaged with Gel Doc (Bio-
Rad). The DNA bands were quantitated with the Quantity One software equipped with 
Gel Doc.  
Primer extension was performed to determine the specificity and efficiency of the 
intra-strand cross-links. DNA was digested with restriction enzymes to yield a suitable 
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template for primer extension. The reaction was incubated at 65°C for 20 minutes to 
inactivate the enzymes. Primers were labeled on 5' ends with p32-ATP by T4 
Polynucleotide Kinase (NEB) and purified with the Sephadex G-25 columns (GE 
Healthcare Life Sciences). Primer extension was done with Taq DNA polymerase 
(Invitrogen) for 15 cycles according to the PCR protocol except only one primer was 
added. The primer extension products were dried by speed vacuum, resuspended in 
formamide loading buffer, and boiled for 5 minutes. Denatured samples were separated 
on 6% DNA sequencing gel containing 8 M Urea. The gel was dried with a filter paper as 
the supporter by Gel Drier (Bio-Rad) and imaged by phosphorimager. The target bands 
were quantitated with the equipped software. 
 
Episomal DNA extraction 
Episomal DNA was extracted with the Modified Hirt procedure as described 
(259). Briefly, 5.5x105 cells were harvested, washed with PBS, and resuspended in 250 µl 
of buffer I (50 mM Tris, pH 7.5, 10 mM EDTA, 100 µg/ml RNase A). Cells were lysed 
by addition of 250 µl of 1.2% SDS. After being incubated at room temperature for 5 
minutes, the lysate was neutralized with 350 µl of buffer II (3 M CsCl, 1 M KAc, and 
0.67 M Acetic acid). After being incubated on ice for 5 minutes, the lysate was clarified 
by centrifugation. The supernatant was recovered and further purified with a miniprep 
column (Qiagen). After being washed with buffer III (80 mM KAC, 10 mM Tris, pH 7.5, 
40 µM EDTA, 60% ethanol), the DNA was eluted with water. 
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Detection of DNA replication intermediates by 2-D agarose gel  
The 2-D agarose gel was performed as described (260). I thank Dr. Katherine 
Friedman for her technical help. COS-1 cells 3.4x105 were plated on a 60 mm dish. After 
being incubated for 24 hours, cells were transfected with 2 µg of DNA. Eight hours after 
transfection, episomal DNA was extracted as described above and resuspended in 10 µl 
water followed by restriction enzyme digestion with XmnI. Digested DNA was separated 
on the first dimension gel made with 0.4% low melting temperature agarose under the 
condition of 1 V/cm for 17 hours in 1xTBE. The lane with the molecular weight marker 
on the gel was cut out and stained.  The locations 1cm below the 1.5 kb molecular weight 
marker and 1cm above the 3 kb molecular weight marker were marked. The gel strips of 
the sample area were excised according to the marked locations on the stained gel and 
embedded into the second dimension gel made with 1.2% agarose containing 0.3 µg/ml 
ethidium bromide. The second dimension gel was run under the condition of 5 V/cm at 
4°C for 4 hours (avoiding intensive light to keep DNA from damaged). The separated 
DNA was transferred onto a nylon membrane followed by Southern hybridization. 
 
Southern hybridization  
The DNA on nylon membranes were fixed by exposure to UVC (254 nm) 
generated from the UV cross-linker (Stratagene). The membrane was incubated with the 
QuickHyb hybridization solution (Stratagene) at 68°C for one hour. The 32P labeled DNA 
probes were generated by random primers labeling kit (Invitrogen) followed by 
purification with the Sephadex G-50 columns (GE Healthcare Life Sciences). The labeled 
probes were denatured and added to the hybridization bottle followed by one hour 
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incubation at 65°C. The membranes were washed with wash buffer [0.1xSSC (15mM 
NaCl and 1.5mM trisodium citrate) and 0.1% SDS] at 65°C for 30 minutes and imaged 
by phosphorimager. The image was quantitated with the equipped software. 
 
Xenopus egg extract preparation 
 The Xenopus Egg extract was prepared as described (139). 
 
Results 
Episomal DNA replicates in cells  
Episomal DNA containing SV40 origin or oriP origin can replicate in cells (41, 
261). They provide convenient model systems to study DNA replication. We intended to 
generate a site specific cross-link on an episome in vitro. After being transfected into 
cells, the episomal DNA replicates in the S phase. The cross-links on episomes are 
expected to stall replication forks.  
To test whether the episomal DNA replicates in cells, an oriP episome, pXX2 was 
transfected into HeLa cells expressing EBV viral protein EBNA-1. The plasmid pXX15 
served as a negative control for DNA lacking the oriP origin. After transfection, episomal 
DNA was recovered from cells and detected by southern blot. The template DNA 
contains dam methylation and is DpnI sensitive. The replicated DNA is resistant to DpnI 
because of lacking dam methylation. 17.8% of the total extracted DNA is the product of 
pXX2 replication in cells in 48hours after transfection, and 26.2% of the total extracted 
DNA is the pXX2 replication products in 72 hours after transfection (Figure 2.1A). In 
contrast, the control episome, pXX15 only yielded 5.1% and 5.3% replication product in 
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Figure 2.1. OriP and SV40 episomes transiently replicate in mammalian cells. 
(A) OriP episome replicates in HeLa cells. Plasmid DNA with oriP origin (pXX2) or 
plasmid DNA lacking oriP origin (pXX15) was transfected into HeLa cells 
expressing EBNA-1. 48 or 72 hours after transfection, episomal DNA was extracted. 
2 µl DNA was digested with KpnI to yield linear DNA, and 8 µl DNA was digested 
with KpnI and DpnI for quantification of replicated DNA. Southern hybridization 
was performed with pXX15 as probe (upper panel). The ratio of DpnI resistant DNA 
to the total DNA represents replication efficiency of oriP episome (lower panel). 
Error Bars represent standard error calculated from 3 experiments. (B) SV40 
episome replicates in COS-1 cells. Plasmid DNA with SV40 origin (pXX23) was 
transfected into COS-1 cells. 12 or 28 hours after transfection, episomal DNA was 
extracted. 4 µl DNA was digested with HindIII to yield linearized DNA. 10 µl DNA 
was digested with HindIII and DpnI for quantification of replicated DNA. Southern 
hybridization was performed with pXX23 as probe. 
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48 hours and 72 hours respectively (Figure 2.1A). The replication efficiencies of the 
plasmid DNA containing SV40 origin in COS-1 cells were determined as 24% and 40% 
in 12 hours and 28 hours respectively (Figure 2.1B).  
 
DNA cross-link can be formed by psoralen at a specific site 
Triple helix forming oligonucleotides (TFO) forms a triple helix structure with 
sequence-specific double stranded DNA (257). The 16 bp polypurine tract (TFO target, 
figure 2.2A) is a good target for triple helix formation with TFO, a previously reported 15 
bp oligonucleotide [Figure 2.2A and reference (262, 263)]. Psoralen is a bi-functional 
photo-reactive DNA intercalator. It preferentially reacts with thymine (264). The psoralen 
was conjugated on the 5'-end of TFO (pso-TFO). Psoralen forms covalent links with its 
furan ring upon exposure to 400nm light generated from xenon lamp and with both furan 
and pyran rings upon UVA irradiation (365 nm), which forms intra-strand cross-link and 
inter-strand cross-link respectively [Figure 2.2B and reference (265)].  
Inter-strand cross-links were formed initially, which were expected to inhibit the 
DNA helicase passing the cross-link site. To determine the cross-linking efficiency, a 
Dra-I protection assay was performed (Figure 2.2C, top panel). The Dra-I site is 
inactivated where the cross-link is formed. Therefore, the disappearance of fragment 1 is 
an indicator of cross-links. The fragment 2 generated by DraI digestion is not affected by 
the cross-links and serves as an internal control for normalization. The pXX2 plasmid 
DNA was incubated with pso-TFO to form triplex followed by exposure to UVA. The 
cross-linked DNA was digested, and separated DNA fragments were quantitated and 
normalized to the plasmid without any treatment (Figure 2.2C, bottom panel, lane 1). 
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Figure 2.2. Cross-link formation at a defined site. (A) An illustration of a 
psoralen conjugated triplex formation oligo (TFO) binding to a double strand DNA 
with specific sequence (TFO target, highlighted in the box), and this forms a DNA 
triplex motif. (B) Two reactions demonstrate how the psoralen is covalently cross-
linked with DNA on single strand by lights generated from Xenon lamp or on double 
strand by UVA light. Intra-strand link occurs between the furan ring of psoralen and 
the DNA bases (top panel, red lines). Inter-strand cross-link occurs through both the 
furan and pyran rings of psoralen (bottom panel, red lines). (C) Analyzing cross-
linking efficiency. The top panel is a demonstration of the method for analyzing the 
cross-linking efficiency. The bottom panel is an analysis of measuring the 
efficiency. TFO target containing plasmid (pXX2) forms a triplex with psoralen-
TFO followed by UVA treatment. DNA was purified by ethanol precipitation. 500 
ng DNA was digested with DraI and separated on 3.5% polyacrylamide gel 
followed by staining with ethidium bromide. The image was taken on Geldoc (Bio-
Rad), and DNA bands were quantitated by Quantity One software (Bio-Rad). The 
ratio of fragment 1 to fragment 2 represents the uncross-linked DNA. 
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22% of the DNA can be digested to produce the fragment 1, which suggests the cross-
linking efficiency about 78% (Figure 2.2C, lane 3). Both triple helix DNA without UVA 
irradiation and DNA treated with UVA irradiation preserve the DraI site to generate the 
fragment 1 (Figure 2.2C, bottom panel, lanes 2 and 5). 
 
Inter-strand cross-links inhibit DNA replication 
OriP origin fires only in one specific direction (261). The pso-TFO with UVA 
irradiation induces a cross-link on the plasmid DNA. Also it leaves a third strand at the 
cross-link site. I generated two DNA constructs with different orientations of TFO targets. 
For the cross-linked pXX2 (pXX2x), the replication fork encounters the psoralen 
mediated cross-link before it encounters the TFO. For the cross-linked pXX3 (pXX3x), 
the fork encounters the 3'-end of the TFO before it encounters the cross-link (Figure 2.3A 
and 2.3B). Both pXX2 and pXX3 forms cross-link with efficiency of 65% and 84% 
respectively (Figure 2.3C).  
To test whether the cross-link inhibits DNA replication, pXX2x and pXX3x were 
transfected into HeLa cells expressing EBNA-1 and allowed to replicate. At 48 hours 
after transfection, the percentages of replicated DNA are not different between the 
uncross-linked DNA pXX2 and the cross-linked DNA including pXX2x (p=0.98) and 
pXX3x (p=0.069, Figure 2.3D). At 72 hours after transfection, 20.4% of recovered 
episome from pXX3x transfected cells was replicated (Figure 2.3C). Although this is 
significantly different from pXX2 transfected cells (26.2%, p=0.002), the inhibition 
efficiency of replication (from 26.2% to 20.4%) does not match with the cross-linking 
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Figure 2.3. Inter-strand cross-link inhibits oriP episome replication in mammalian 
cells. (A) A diagram of oriP episomes used. (B) Demonstration of two oriP derived 
episomes containing different directions of the TFO target (pXX2 and pXX3). (C) PXX2 
and pXX3 form triplex followed by induction of cross-link. The cross-linking efficiency 
was analyzed by Dra I protection assay as previously. (D) Episomes (pXX2 and pXX15) 
or episomes with cross-links (pXX2x and pXX3x) were transfected into HeLa cells 
expressing EBNA-1. 48 or 72 hours after transfection, episomes were extracted. 2ul of 
DNA was linearized with Kpn I, and 8ul of DNA was digested with Kpn I and Dpn I. 
Digested DNA was separated on agarose gel and quantitated by Southern blot with 
pXX15 as probe (top panel). The ratio of Dpn I resistant DNA to total DNA was presented 
(bottom panel). 
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efficiency of pXX3x (84%). Also the pXX2x did not inhibit replication compared to 
pXX2 at 72 hours after transfection (p=0.089, Figure 2.3D). 
The SV40 episome has higher replication efficiency than the oriP episome 
because it can replicate multiple rounds in one cell cycle. We then tested whether the 
inter-strand cross-link inhibits replication with the SV40 episome model system. The 
cross-link was formed on pXX23, an SV40 episome (Figure 2.4A). The cross-linking 
efficiency was determined by DraI protection assay to be 84% (Figure 2.4B).  
The assay of competitive replication of SV40 episomes can determine replication 
efficiency (257). In this assay, another SV40 plasmid with a different size than pXX23 
(pcDNA3.1) was used as an internal control for normalization. The pLNCX2 plasmid 
does not contain SV40 origin and served as a negative control. The pXX23 DNA was 
cross-linked with two different efficiencies, 84% (pXX23xa) and 42% (pXX23xb). The 
ratio of replicated DNA to the internal control was calculated and normalized to the 
uncross-linked pXX23. The replication efficiencies of pXX23xa and pXX23xb are about 
30% and 70% of the uncross-linked pXX23 respectively (Figure 2.4C). The sample of 
pXX23/UVA is pXX23 treated with UVA without incubation with TFO oligo, and it 
serves as a control for UVA treatment. The pXX23/UVA episome replicates efficiently 
as pXX23. These data suggest that the inter-strand cross-link inhibits DNA replication of 
SV40 episome.  
 
The replication fork is paused at the inter-strand cross-link site 
Although the inter-strand cross-link inhibits replication of SV40 episome, it is 
unclear whether the origin is fired on the cross-linked DNA. Two-dimensional agarose 
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Figure 2.4. Inter-strand cross-link inhibits SV40 episome replication in COS-1 cells. 
(A) A diagram of SV40 episome used (pXX23). (B) Inter-strand cross-link was achieved on 
pXX23 as previously, and the cross-linking efficiency was determined by DraI protection 
assay. (C) PXX23, cross-linked pXX23 [pXX23xa (84% cross-linking efficiency) and 
pXX23xb (42% cross-linking efficiency by mixing 50% of pXX23 and pXX23a)], pXX23 
treated with UVA 1.8 J/m2, and pLNCX2 (no SV40 origin) were transfected into COS-1 
cells with pcDNA3.1 (containing SV40 origin) as the internal control. 24 hours after 
transfection, the episome DNA was extracted and digested with HindIII and DpnI followed 
by southern blot with the AMP gene fragment as probe (top panel). Lane 1, 2, and 3 are 
plasmid DNA linearized with HindIII only and served as control for DNA size. The 
replicated pXX23 DNA was quantitated and normalized to pXX23 without cross-link 
(bottom panel). Error Bars stand for SE from 3 experiments. 
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gel has been used to map DNA replication intermediates (260). In the first dimension, 
DNA is separated by size. In the second dimension, DNA is separated by complexity. 
Theoretically, the smallest and the largest DNA fragments migrate to point “a” and point 
“e” respectively (Figure 2.5A). The most complex DNA migrates to point “c” (Figure 
2.5A). The fork movements from point “a” to point “e” were exhibited for the uncross-
linked (pXX23) and the cross-linked (pXX23x) plasmid DNA (Figure 2.5B). In theory, 
the replication fork of pXX23 moves from point “a” to point “e” gradually, and 
replication intermediates are “Y” shaped DNA (Figure 2.5B, left panel). The replication 
fork of pXX23x moves from point “a” to point “d” and stops at point “d” where the 
cross-link occurs. The other fork from the opposite direction encounters this stalled fork 
at the cross-link site. Therefore, a unique “X” shaped DNA is generated (Figure 2.5B, 
right panel). 
The pXX23 episome or cross-linked pXX23 (pXX23x, figure 2.5B) were 
transfected into COS-1 cells to allow DNA replication. Episomal DNA was digested to 
produce the DNA fragments from site “a” to site “e”. Two-dimension agarose gels were 
used to separate replication intermediates followed by southern blot to detect the 
replication intermediates. The result matches very well with the theoretic fork movements 
(Figure 2.5C). The dot at site “d” indicated that the replication fork of pXX23x is paused 
(Figure 2.5C, right panel). The dot at site “e” reflects that the “X” shaped DNA was 
formed when two replication forks encounter with the cross-link (Figure 2.5C, right 
panel). The data here indicates that the cross-link on DNA does not inhibit origin firing 
but stalls the replication fork. 
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Figure 2.5. Inter-strand cross-link stalls DNA replication forks. (A) 
Demonstration of analyzing DNA replication intermediates by 2-D agarose gel. In 
the first dimension, DNA is separated by size (a indicates unreplicated DNA, and e 
indicates fully replicated DNA). In the second dimension, DNA is separated by 
complexity (c marks the most complex DNA). (B) Demonstration of pXX23 or 
cross-linked pXX23 (pXX23x) replication intermediates. a to e represent the 
locations of replication forks move to and correspondent DNA fragments generated 
after digestion with XmnI. (C) PXX23 or pXX23x was transfected into COS-1 cells. 
8 hours after transfection, episomal DNA was extracted and digested with XmnI 
followed by separation on 2-D agarose gel. Southern blot was performed to detect 
the DNA replication intermediates. 
 
 64 
An intra-strand DNA cross-link is formed at a specific site 
We then tested whether the stalled replication forks activate the ATR dependent 
checkpoint. Chk1 is phosphorylated by ATR kinase after DNA damage and replication 
stress (133). There was no detectable Chk1 phosphorylation induced in cells transfected 
with inter-strand cross-linked DNA of oriP or SV40 episomes (data not shown). Not all 
stalled replication forks cause ATR activation. It is reported that the functional 
uncoupling of replication polymerases and helicases generates long stretches of single-
stranded DNA (ss-DNA), and this ss-DNA is required to activate ATR (139, 266). It is 
possible that both polymerases and helicases are stalled at the inter-strand cross-link site 
on replicating episomes. This may inhibit the formation of long stretches of ss-DNA.  
A cross-link on one strand of DNA (intra-strand cross-link) might allow DNA 
helicases to pass the cross-link site but prevent the DNA polymerase from passing. The 
400nm wavelength light generated from a Xenon lamp can induce only the furan ring of 
psoralen cross-linked with thymidine [Figure 2.2B and reference (265)]. In the model 
system of SV40 episome, the other fork encounters with the stalled fork indicated by the 
“X” shaped DNA (Figure 2.5C). I thought that intra-strand cross-link on oriP episome 
would uncouple the DNA helicases and DNA polymerase for a longer time than on SV40 
episome because oriP origin is a unidirectional (46). In addition, this characteristic of 
oriP episome allows us to distinguish the fork stalling by a lesion on the leading and the 
lagging strand.   
The pXX27 and the pXX28 constructs were generated with two different 
orientated TFO targets similar to pXX2 and pXX3 (Figure 2.6A). To determine the 
specificity and efficiency of intra-strand cross-links, we performed primer extension with 
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Figure 2.6. Intra-strand cross-links formation. (A) A diagram of oriP episomes used. Two 
oriP episomes containing different directions of the TFO target (pXX27 and pXX28) form 
inter- and intra-strand cross-links (right panel). (B) The schematic demonstration of analyzing 
the cross-link specificity on individual strands by primer extension. The pCEP4PPT-1F (1F) 
primer pairs to the lagging strand, and the pCEP4PPT-1R (1R) primer pairs to the leading 
strand. After inter- (pXX27x and pXX28x) or intra-strand cross-links (pXX27v and pXX28v) 
were formed on DNA, DNA was digested with NcoI and XmnI to yield a fragment suitable as 
the template for primer extension with the p32 labeled primers. Theoretic products were 
marked with single strand DNA length (arrows indicate the directions of primer extension). 
(C) Primer extension was performed with both 1F and 1R primers for the intra- (lane 2 and 4) 
and inter-strand cross-linked DNA (lane 1 and 3). The products were separated on 6% DNA 
sequencing gel. Lane 7 is the control for no cross-link (pXX28 plasmid digested with XmnI 
and NcoI). Lane 8 is the control for 100% cross-link (pXX28 plasmid digested with XmnI, 
NcoI, and DraI). D, Cross-link efficiencies were calculated on each strand and plotted. 
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two primers flanking the cross-link sites. Inter- and intra-strand cross-links were formed 
on pXX27 and pXX28. The cross-linked DNA was digested by restriction enzymes (NcoI 
and XmnI) to generate a suitable template for primer extension. The primer extension 
products were separated on DNA sequencing gel followed by exposure to phosphor 
imager. The theoretic products are shown in Figure 2.6B.  
The digested pXX28 serves as a negative control for 0% cross-linking efficiency 
(Figure 2.6C, lane 7). Because the cross-link site is also a cleavage site of DraI, pXX28 
was digested with NcoI, XmnI, and DraI to serves as a positive control for 100% cross-
linking efficiency (Figure 2.6C, lane 8). While TFO forms a triplex with plasmid DNA, it 
does not block primer extension (Figure 2.6C, lanes 5 and 6).  The cross-link will stop 
primer extension at the cross-link site due to DNA polymerase stalling. A shorter product 
is generated with the template of cross-linked DNA than the template without cross-links. 
For intra-strand cross-linked pXX27 (pXX27v), a 138 bp fragment is produced with the 
primer 1R, but not 1F (Figure 2.6C, lane 2). For intra-strand cross-linked pXX28v, a 116 
bp fragment is produced with the primer 1F but not 1R (Figure 2.6C, lane 4). This proved 
that the cross-link occurred on the specific strand. The intra-strand cross-linking 
efficiency is determined by the percentage of shorter products in total products. About 
76% and 80% strand-specific cross-link were achieved on pXX27v and pXX28v (Figure 
2.6D). 
The double strands of inter-strand cross-linked DNA can not be separated 
completely. This can cause two strand re-annealed during primer extension, which 
inhibits DNA polymerase moving. Therefore, the cross-linking efficiency of inter-strand 
cross-link can not determined by the above method. Instead, it was determined by the loss 
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of the larger fragment (564 bp for the primer 1F and 671 bp for the 1R primer; Figure 
2.6C, lanes 1 and 3). About 81% and 76% of each strand were cross-linked on pXX27x 
(Figure 2.6D). Similar cross-link efficiencies were achieved on pXX28x. The inter-strand 
cross-linking efficiency was also determined with DraI protection assay. The cross-link 
efficiencies determined by these two methods were consistent (data not shown).  
 
Intra-strand cross-linked DNA induces Chk1 phosphorylation 
There was no detectable Chk1 phosphorylation in cells transfected with the inter- 
and intra-strand cross-linked oriP plasmid. I was unable to prove that the cross-link on 
oriP plasmid can stall replication forks partially because the replication efficiency of oriP 
plasmid in cells is very low (once per cell cycle).  
The Xenopus egg extract system has been used to study DNA replication as a 
model system (40). In this system, the concentrated S phase components support a robust 
DNA replication in vitro. In addition, any region on DNA can serve as a replication 
origin. In collaboration with Dr. Karlene Cimprich laboratory, we tested whether the 
cross-linked plasmid induces Chk1 phosphorylation in this system. Because origin fires 
in both directions, we were unable to distinguish the intra-strand cross-link on the leading 
strand and the lagging strand. The cross-linked pXX27 plasmid was used here (Figure 
2.7). The addition of pXX27 causes Chk1 phosphorylation induced by aphidicolin 
(Figure 2.7, compare lanes 7 and 8). The addition of intra-strand cross-linked pXX27 
(pXX27v) induces Chk1 phosphorylation but the control of Xenon light treated does not 
(Figure 2.7, compare lanes 11 and 12). In contrast, the inter-strand cross-linked pXX27 
(pXX27x) did not induce detectable Chk1 phosphorylation. Moreover, inhibition of DNA  
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 Figure 2.7. Intra-strand cross-linked DNA causes Chk1 
phosphorylation in Xenopus egg extracts. Equal amount of untreated 
plasmid (Control), inter-strand cross-linked plasmid (pXX27x), inter-strand 
cross-link control plasmid (pXX27 + UVA), intra-strand cross-linked 
plasmid (pXX27v), and intra-strand cross-link control plasmid (pXX27 + 
Xe light) were incubated with Xenopus egg extract in the presence and 
absence of Geminin (30 minutes, 45 minutes and 60 minutes). Chk1 
phosphorylation was examined by immunoblotting with an antibody to 
phospho-specific Chk1. The control plasmid also was incubated with the 
egg extract in the presence of aphidicolin to serve as a positive control. 
This experiment was performed by Dr. Karlene Cimprich laboratory.   
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replication by addition of Geminin abolishes the Chk1 phosphorylation induced by the 
intra-strand cross-link (Figure 2.7, compare lanes 5 and 11). This result suggests that the 
combination of the cross-linked episomes with Xenopus egg extract system is an ideal 
system to study replication fork stalling.         
 
Distinguishing cross-links on the leading and lagging strand in the egg extract system  
Any region on DNA can serve as a replication origin, and any origin fires in both 
directions in the egg extract system. Although the origin on DNA is not sequence specific, 
only one origin occurs per 10kb DNA in general (267). This characteristic provides a 
strategy to distinguish the cross-link on the leading and lagging strand. One origin per 
molecule was achieved by limiting the size of plasmid DNA to less than 10 kb. Since the 
inter-strand cross-link does not induce Chk1 phosphorylation, we can generate a 
psoralen-APRT-mediated inter-strand cross-link to block one direction of fork 
progression [Figure 2.8A and reference (258)]. The TFO target is 500 bp away from the 
APRT target (Figure 2.8B). Therefore, 95% of the forks will be initiated from the larger 
fragment between TFO target and APRT target. Thus, 95% of intra-strand cross-link 
generated by pso-TFO is specifically on leading or lagging strand dependent of 
orientation of TFO target. 
Although the SV40 origin is not committeed to fire in the egg extract system, we 
used an SV40 episome as the vector to clone APRT and TFO targets because this 
episome can replicate robustly in COS-1 cells (Figure 2.8B). The pso-APRT-mediated 
inter-strand cross-link can block one direction of replication fork initiated from the SV40 
origin (Figure 2.8B, bottom panel). This allows the DNA helicase from the other fork to 
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Figure 2.8. Modified SV40 constructs for studying leading and lagging 
strands replication stress. (A) APRT oligo forms a triplex with its target 
DNA. Psoralen-mediated cross-links can be induced by UVA through the 
thymidines on both strands (t). (B) A diagram of plasmid DNA with two 
adjacent APRT target sites and one TFO target site (top panel). Illustration 
of pXX60 and pXX61 forms intra-strand cross-links. The TFO target is 
500 bp away from the APRT target. 
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unwind template DNA longer when the fork is stalled by the cross-link on the leading or 
lagging strand separately in COS-1 cells. The oligonucleotide APRT efficiently forms 
triple helix with the APRT target (258). The psoralen-APRT-mediated inter-strand cross-
link was achieved about 95% upon UVA irradiation (data not shown). Then the DNA 
formed triple helix with pso-TFO followed by exposure to the light of 400 nm 
wavelength. The cross-links on APRT target was remained after this treatment. About 
70% cross-link was achieved on the leading or lagging strand specifically determined by 
primer extension (data not shown). We will determine whether different levels of Chk1 
phosphorylation are induced by the cross-link on the leading and lagging strand. Also this 
modified episome in combination with the egg extract system provides an ideal system to 
study protein recruitment to the stalled forks by CHIP.  
 
Discussion 
To understand how the stalled forks are stabilized, we need to identify what 
proteins are recruited to the stalled forks. Currently, protein foci formation co-localized 
with the replication fork is detected by immunofluorescence microscopy. Here we 
proposed to establish a system to study protein localization on stalled forks by CHIP, a 
higher resolution and more sensitive approach than immunofluorescence microscopy. 
CHIP requires the DNA sequence information for PCR. Therefore, a model system with 
stalled replication forks on the defined sites is needed. The combination of the cross-
linked episomes with Xenopus egg extract system is an ideal system to detect protein 
localizations on the stalled replication fork by CHIP. This is supported by the evidence 
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that intra-strand cross-linked DNA causes Chk1 phosphorylation in the egg extract 
system (Figure 2.7). 
A similar system was established to detect protein localization on replicating 
episomes by CHIP (33). In this system, plasmid replication is stalled by biotin-
streptavidin complex. The biotin-streptavidin complex blocks DNA helicase and DNA 
polymerases. Replication proteins including Mcm2-7, Cdc45, and GINS are detected to 
be enriched on the site of stalled forks. The system I established is expected to 
differentiate the inter-strand cross-link and intra-strand cross-link. Also with the modified 
episome containing APRT and TFO targets, we will be able to differentiate the stalled 
forks on the leading strand and the lagging strand (Figure 2.8B). 
We proposed to detect protein recruitment to the stalled forks by CHIP. This 
method requires a high quality of antibody to proteins known on the stalled forks. Our 
main targets are checkpoint proteins including RPA, ATR, and ATRIP. There is only one 
report about detecting these proteins on DNA by CHIP (268). I was unsuccessful to 
detect these proteins on stalled fork in cells by CHIP under the condition as described 
(268). Then I tried an alternative approach to detect protein localization on DNA in cells. 
A biotin group was conjugated to the 3' end of pso-TFO, and the proteins bound on the 
stalled forks can be pulled down by streptavidin beads. The proteins on the beads can be 
detected by western blot or proteomics approach. Compared with CHIP, the pull-down 
method is less sensitive because PCR is used to amplify signal in CHIP assay. Therefore, 
a lot more samples are needed to detect proteins by the pull-down assay. I was 
unsuccessful to detect ATR, ATRIP, or RPA on the stalled forks in cells by the pull-
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down assay. However, it is worth to try both CHIP and streptavidin pull-down 
approaches in the egg extract system with the cross-linked plasmid DNA. 
The functional uncoupling of replication polymerases and helicases generates 
long stretches of single-stranded DNA (ss-DNA), and this ss-DNA is required to activate 
ATR (139, 266). On a circled episome with a bidirectional origin, the DNA helicase of 
one fork is functionally uncoupled from the DNA polymerases when the fork encounters 
the intra-strand cross-link. The other moving fork will inhibit the activity of this DNA 
helicase by limiting the template. The functional uncoupling of DNA helicase and DNA 
polymerase generates ss-DNA, and longer stretches of ss-DNA can cause higher levels of 
ATR signaling (139). Therfore, the intra-strand cross-link on an episome with a 
unidirectional origin may cause higher levels of Chk1 phosphorylation than on an 
episome with a bidirectional origin. The intra-strand cross-link on oriP episome does not 
cause detectable Chk1 phosphorylation. This may due to the low replication efficiency of 
oriP episomes. The SV40 episome replicates robustly in COS-1 cells. The pso-APRT-
mediated inter-strand cross-link on pXX60/61 can block one direction of replication fork 
initiated from the SV40 origin (Figure 2.8B, bottom panel). This will extend the duration 
time of the founctional uncoupling of DNA helicase and polymerase by pso-TFO-
mediated intra-strand cross-link, which may increase the level of Chk1 phosphorylation 
to be detected.   
The replications of the SV40 and the oriP episomes were inhibited by the inter-
strand cross-link (Figures 2.3 and 2.4). The inhibition efficiency was proportional to the 
cross-linking efficiency for the SV40 episome. However, the inhibition efficiency was 
not matched with the cross-linking efficiency for the oriP episome. This is due to the 
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methodology used to detect replicated DNA, which is determined by the resistance to 
DpnI. Two rounds of replication are required for replicated DNA to be DpnI resistant. A 
minimum time of 48 hours is required for oriP DNA replication to be detected with this 
method.  The cross-link on DNA possibly has been removed by the DNA repair proteins 
in 48 hours. SV40 episome replicates multiple rounds in one cell cycle. Therefore, DNA 
replication can be detected at earlier time point (Figure 2.4).  
Although the fork stalling of SV40 episome by the inter-strand cross-link can be 
detected by 2-D agarose gel (Figure 2.5C), detecting the replication intermediates was 
unsuccessful for oriP episomes replicated for 24 hours. There were two possible reasons 
for this difficulty. One, the oriP origin only fires once per cell cycle (50), and SV40 
plasmid replicates constantly in S phase (41). Two, less copy numbers of the oriP 
episome can be replicated than SV40 episomes (Figure 2.1). A lot more sample is 
required to detect the replication intermediates for oriP episome than SV40 episome. 
Transfection of the inter-strand cross-linked oriP or SV40 episomes into cells 
does not activate Chk1 phosphorylation (data not shown). Functional uncoupling of the 
replication helicases with DNA polymerases activates ATR (139, 266). It is unclear 
whether the helicases can pass the inter-strand cross-link. I thought that the cross-link on 
one strand of the double stranded DNA template would provide a better chance to 
uncouple the replication helicases and DNA polymerases. The strand-specific cross-link 
was achieved on the oriP episome that targeted the leading strand and the lagging strand 
individually (Figure 2.6). Although the intra-strand cross-linked oriP episomes did not 
induce Chk1 phosphorylation in cells (data not shown), they are able to induce Chk1 
phosphorylation in Xenopus egg extract system (Figure 2.7). The possible explanation is 
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that DNA is replicated more synchronized and robustly in the Xenopus egg extract 
system than in cells. Therefore, the combination of the cross-linked episomes with 
Xenopus egg extract system is an ideal system to detect protein localizations on the 
stalled replication fork.  
In summary, we established a model system to study cellular responses to a 
stalled DNA replication fork. In this model system, one fork is stalled at the defined site. 
This model system with a single fork stalling provides a focused window to study protein 
recruitments to the stalled fork. Although we have not identified any checkpoint protein 
on the stalled fork in cells yet, the Xenopus egg extract system may provide better chance 
to identify protein recruitment to stalled forks. Also, this model system can be used to 
study how different DNA damages are repaired for the inter-strand cross-links, leading 
strand cross-links, and lagging strand cross-links. 
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CHAPTER III  
 
REGULATION OF ATR SIGNALING BY ATRIP AND CINP1 
 
Summary 
ATR regulates cellular responses to DNA damage and replication stress. ATRIP 
is a constitutive interaction partner of ATR and critical for ATR activation. Post-
translation modification and protein-protein interaction are common mechanisms for 
regulation of protein functions. Mass spectrometry was used to identify phosphorylation 
sites on the ATRIP-ATR complex. Two novel phosphorylation sites on ATRIP were 
identified, S224 and S239. S224 matches a consensus site for cyclin-dependent kinase 
(Cdk) phosphorylation and is phosphorylated by Cdk2-cyclin A in vitro and in vivo. 
Mutation of S224 to alanine causes a defect in maintaining the ATR-ATRIP dependent 
G2-M checkpoint response to ionizing and ultraviolet radiation. We also identified CINP 
as a novel regulator of ATR signaling. Furthermore, CINP interacts with ATRIP and 
regulates phosphorylation of ATRIP on S224. Thus, Cdk2 regulates ATR signaling in 
response to DNA damage through CINP and ATRIP S224 phosphorylation. 
                                                
1 A portion of this chapter has been previously published in ref 175. Myers, J.S., et 
al. (2007) Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the 
G2-M checkpoint response to DNA damage. Cancer Res, 67, 6685-90.    
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Introduction 
The ATM (ataxia-telangiectasia mutated) and ATR (ATM and Rad3-related) 
kinases function at the apex of cell cycle checkpoint signaling pathways (92, 133, 269). 
ATM functions primarily in response to double strand breaks throughout the entire cell 
cycle. ATR activation occurs primarily in S-phase in response to long stretches of 
replication protein A (RPA) coated single strand DNA (hereafter RPA-ssDNA) (134, 266, 
270). ATM and ATR share many biochemical and functional similarities. Both are large 
protein kinases with significant sequence homology and a strong preference to 
phosphorylate serine or threonine followed by glutamine (S/TQ) (61, 92-94). However, 
ATR is essential for cell proliferation in humans and mice, whereas ATM is not (163, 
231, 232).  
ATR, ATM, and DNA-PK are members of a phosphoinositide 3-kinase related 
kinases (PIKKs) family. Phosphorylation is a common regulatory mechanism of kinase 
activation. ATM is autophosphorylated on three different sites, S367, S1893, and S1981. 
These phosphorylation sites are important for ATM function (124, 125). ATM S1981 
phosphorylation promotes a conformation change of ATM from inactive dimers to active 
monomers (124). DNA-PK contains two clusters of S/TQ phosphorylation required for its 
activity. These sites are phosphorylated by autophosphorylation, ATM, or ATR (271, 
272). Therefore, we propose that ATR activity is also regulated by phosphorylation. This 
is supported by the evidence that both ATR and ATRIP can be phosphorylated by ATR 
in an in vitro kinase assay (163). However, no phosphorylation sites on ATR-ATRIP 
have been described.  
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Protein-protein interaction is another common mechanism to regulate protein 
functions. ATR has a constitutive interaction partner, ATRIP (163). This is a key 
difference between ATR and ATM. ATRIP regulates ATR activation in many aspects. 
ATRIP and ATR proteins mutually stabilize each other (163). The N-terminal region of 
ATRIP is required to localize the ATR-ATRIP complex to DNA damage sites through an 
interaction with RPA (137, 160). The ATRIP coiled-coil domain contributes to ATRIP 
oligomerization, stabilization of the ATR-ATRIP complex, and Chk1 phosphorylation 
after DNA damage (168). The ATRIP C-terminal region containing residues 658-684 is 
required for the formation of ATR-ATRIP complex (160). Both the formation of ATR-
ATRIP complex and ATR kinase activity are required for the complex localization to 
DNA damage sites (119, 160, 172). Moreover, TopBP1 is an ATR kinase enhancer, and 
its interaction with the ATR depends on the formation of ATR-ATRIP (217, 218, 273). 
Here we identified two phosphorylation sites on ATRIP, S224 and S239. Using 
phospho-peptide-specific antibodies and mutational analysis, we have determined that 
phosphorylation of ATRIP S224 is dependent on Cdk2 kinase activity and critical for 
ATR-dependent checkpoint responses after DNA damage. Furthermore, we identified 
Cdk2-interacting protein (CINP) as a novel ATRIP interacting protein. CINP is also a 
regulator of the ATR-ATRIP checkpoint kinase complex. Thus, in addition to being a 
target for ATR-dependent checkpoint responses, Cdk2 also regulates the ATR checkpoint 
kinase through ATRIP and CINP. 
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Materials and Methods 
Antibodies  
The following antibodies were purchased: γH2AX (Upstate Biotechnology), ATR 
and CHK1 (Santa Cruz Biotechnology), GAPDH (Chemicon), Flag (Sigma), MCM2 (BD) 
and HA.11 (Covance). The phosphopeptide-specific antibodies to pS345 of CHK1, 
pS317 of CHK1, and pS15 of p53 were obtained from Cell Signaling Technology. 
Antibodies against ATRIP and ATRIP pS224 were generated and described previously 
(163, 175). Mouse polyclonal antibodies to full-length recombinant CINP were generated 
by the Vanderbilt Monoclonal Antibody Core (VMAC). 
 
Cell culture, cell lines, cell treatments, and transfections  
HeLa, U2OS, and HEK293T cell lines were grown in DMEM (Invitrogen) 
supplemented with 7.5% fetal bovine serum at 37°C in 5% CO2. RPE-hTERT cells were 
grown in DMEM/F12 (Invitrogen) supplemented with 10% fetal bovine serum and 0.2% 
sodium bicarbonate. U2OS cell lines expressing the pLPCX empty vector, HA-ATRIP, 
and HA-ATRIP S224A and RPE-hTERT cells expressing HA-ATRIP were established 
by retrovirus infection followed by puromycin selection. UV treatment was conducted 
with a Stratalinker (Stratagene). IR treatment was done with a 137Cs irradiator with a dose 
rate of ~1.4 Gy/min. Plasmid DNA transfections were done with LipofectAMINE 2000 
(Invitrogen), and siRNA transfections were done with OligofectAMINE (Invitrogen) 
according to manufacturer’s instruction. For G2-M checkpoint assays with ATRIP and 
the ATRIP S224A mutant, cells were transfected twice in day one and day two. 
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RPE-hTERT cell synchronization  
Twenty-four hours after siRNA transfection, RPE-hTERT cells were plated from 
one well in a 6-well plate to one well in a 12-well plate. The cells were incubated for 48 
hours. This is considered time 0 when cells were arrested in G0 by contact inhibition. 
Cells were then plated from one well to one 100 mm dish, allowing cells to release from 
the arresting and re-enter the cell cycle. Cells were in S phase after incubation for 24 
hours. DNA content was analyzed for asynchronized, arrested, and released cells by flow 
cytometry with propidium iodide staining. 
 
DNA content analysis 
Cells were harvested, washed with PBS, and fixed with 70% cold ethanol. After 
fixation, cells were pelleted and resuspended in PBS containing propidium iodide and 
RNase followed by incubation at 37°C for one hour. Cells were analyzed on a BD 
Biosciences FACSCalibur.  
 
DNA constructs and siRNA targeting sequences  
Site-directed mutagenesis was performed using QuickChange (Stratagene). All 
DNA constructs generated using PCR were confirmed by sequencing. DNA constructs 
for retrovirus infection were generated with the pLPCX vector (BD). DNA constructs for 
transient gene expression were generated with the pcDNA3.1 vector (Invitrogen).  Non-
specific siRNA (5'-ATGAACGTGAATTGCTCAA), siRNA targeting endogenous 
ATRIP (5'-GGTCCACAGATTATTAGAT), and siRNA targeting CINP [CINP-1 (5'-
AAACCTGTCTTATCTGTCA), CINP-2 (5'-GCGGCTGATTGGCACAATT), CINP-4 
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(an ON-TARGETplus SMARTpool duplex including 5'-CAAGGGAATTTGTGAACTA, 
5'-GAACTGTAACGCCCAGAAA, 5'-CGCATAAGCTCTTGGAGAT, and 5'-
GAAAAGGTGTGTCTGGAAT), CINP-6 (5'-GCGGCTGATTGGCACAATTTA)] were 
purchased from Dharmacon, Inc. except CINP-2, which was from Invitrogen.         
 
Total cell lysate and nuclear extracts preparation 
Total cell lysates were prepared by lysing cell pellets with different lysis buffers 
on ice for 30 minutes followed by centrifugation according to the approaches of 
individual experiments. CHAPS lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 0.75% 
CHAPS, 0.1% triton x-100) was used for protein co-immunoprecipitation. For 
immunoblotting, NP-40 lysis buffer (50 mM Tris, pH 7.5, 200 mM NaCl, 1% Igepal) was 
used. Both lysis buffers were supplemented with protease inhibitors including 5 µg/ml 
aprotinin, 5 µg/ml leupeptin, 1 mM NaF, 20 mM β-glycerolphosphate, 1 mM sodium 
vanadate, 1 mM dithiothreitol, and 1 mM phenylmethylsulfonate (PMSF). For 
preparation of nuclear extracts, two 10cm dishes of 90-100% HEK293T cells were 
harvested. The cells were washed twice with PBS and resuspended in 1 ml cold 
hypotonic buffer (20 mM HEPES-KOH, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.2 mM 
PMSF, 0.5 mM DTT). Cells were then spun at 2500xg for 3 min at 4oC, and the 
supernatant was discarded. Cells were resuspended in 0.4 ml cold hypotonic buffer and 
allowed to swell on ice for 10 minutes. The suspension was homogenized in a small 
dounce homogenizer with ten up and down strokes and spun at 3300xg for 6 min at 4oC. 
Then, 250 µl of high salt buffer (20 mM HEPES-KOH, pH 7.9, 25% glycerol, 1.5 mM 
MgCl2, 350 mM NaCl, 0.2 mM PMSF, 0.5 mM DTT, 1 mM NaF, 10 mM Sodium 
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Vanadate, 10 mM β-glycerolphoshpate, 5 µg/ml aprotinin, 5 µg/ml leupeptin) was slowly 
added to the pellet in a drop wise with occasional flicking. The suspension was placed on 
an end-over-end rotator for 30 min at 4oC. The extract was spun at 16,000xg for 10 min 
at 4oC to get rid of the insoluble proteins. The supernatant was recovered, mixed with 200 
µl no salt buffer (20 mM HEPES-KOH, pH 7.9, 20% glycerol, 0.2 mM PMSF, 0.1% 
Tween 20), and spun at 16,100xg for 5 min at 4oC. The supernatant (the nuclear extract) 
was recovered. 
 
Co-immunoprecipitation  
HEK293T cells were transiently transfected with constructs encoding tagged ATR, 
ATRIP, and CINP. Cells were harvested and lysed in CHAPS lysis buffer. Anti-Flag 
agarose beads (Sigma) were added to clarified cell lysates, and the mixture was incubated 
at 4°C for 3 hours. The beads were washed with lysis buffer twice and lysis buffer 
containing 0.5% triton x-100 once. Precipitated proteins were eluted and separated on 
SDS-PAGE gels followed by immunoblotting. For co-immunoprecipitations with 
endogenous protein, total cell lysates from HeLa cells or nuclear extracts from HEK293T 
cells were incubated with mouse anti-CINP antibodies and protein G agarose beads 
(Invitrogen) at 4°C for 3 hours. The beads were washed with TGN buffer (Tris, pH 8.0, 
150 mM NaCl, 1.0% Tween 20, 10% glycerol) supplemented with protease inhibitors. 
Precipitated proteins were eluted and separated by SDS-PAGE followed by 
immunoblotting. 
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Cdk2-cyclin A Kinase assay  
HA-ATRIP-Flag-ATR complexes were purified from transiently transfected 
HEK293T cells. Total cell lysates were prepared with TGN buffer supplemented with 
protease inhibitors. Anti-HA agarose beads (Sigma) were added to clarified cell lysates 
and incubated for 3 hours. The beads were washed with TGN buffer, TGN buffer 
containing 0.5 M LiCl, and 1xCdk2 kinase buffer (New England Biolabs). Kinase 
reactions were started by the addition of 28 units of Cdk2-cyclin A complexes (New 
England Biolabs) and 10 µCi γ32P-ATP (3,000 Ci/mM) in kinase buffer supplemented 
with 20 µM ATP directly to the HA-ATRIP-Flag-ATR complexes on the beads. 
Reactions were incubated at 30°C for 20 minutes and stopped by the addition of SDS 
sample buffer and boiling. Reactions were separated on duplicate SDS-PAGE gels. One 
gel was stained with coomassie blue, dried, and exposed to X-ray film. Proteins from the 
duplicate gel were transferred to nitrocellulose followed by immunoblotting with 
antibodies for ATR and ATRIP.  
 
G2-M checkpoint assay 
U2OS cells were transfected with siRNA as described above. Three days after 
transfection cells were irradiated with IR or UV followed by incubation in the presence of 
1 µM nocodazole to capture cells that entered mitosis. Cells were incubated for 16 hours 
after being treated with 5 Gy of IR or 8 hours after being treated with 25 J/m2 of UV. All 
cells were harvested and fixed with Carnoy’s fixative solution. Cells were stained with 
4’6-diamidino-2-phenylindole (DAPI) and imaged with microscopy. Mitotic spreads 
were counted. At least 300 cells were counted for each sample. Alternatively, all cells 
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were harvested and fixed with 70% ethanol. Cells were permeabilized followed by 
staining with anti-phospho-histone H3 S10 antibody and propidium iodide. Mitotic cells 
were quantitated by flow cytometry analysis. 10,000 cells were analyzed for each sample.  
 
Immunofluorescence  
U2OS cells were cultured on cover slips for 24 hours, rinsed with PBS once, and 
fixed with 3% paraformaldehyde for 10 minutes at room temperature. After being washed 
with PBS, cells were permeabilized with 0.5% triton X-100 for 10 minutes on ice 
followed by washing with PBS. After being blocked at room temperature for 15 minutes 
with 5% BSA/PBS, cells were incubated with primary antibodies followed by washing 
with PBS. Then cells were incubated with fluorophore conjugated secondary antibody 
followed by washing with PBS. Cells were counterstained with DAPI, and cover slips 
were mounted on microscope slides. For γH2AX immunostaining, cells were cultured on 
cover slips two days after siRNA transfection. After 24 hours of culturing, cells were 
incubated with mouse anti-γH2AX (pS139) antibody as primary antibody and rhodamine 
conjugated goat anti-mouse antibody (Jackson ImmunoResearch) as secondary antibody. 
Cells were imaged with a Zeiss Axioplan microscope equipped with a Zeiss camera and 
software.  
 
Immunoblotting  
 Proteins transferred onto nitrocellulose were incubated with primary antibodies 
and secondary antibodies. Secondary antibodies conjugated with horseradish peroxidase 
(HRP) were detected by an enhanced chemiluminescent lighting kit (ECL, GE 
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Healthcare), and the blots were exposed to X-ray film followed by development. Scanned 
images were quantitated with NIH image software. Secondary antibodies conjugated with 
IRDye (LI-COR Biosciences) were detected by an Odyssey scanner, and the images were 
quantitated with the equipped software. 
 
Results 
ATRIP S224 is phosphorylated by Cdk2 
 To identify post-translational modifications on the ATR-ATRIP complex, the 
complex was purified from HeLa cells using affinity chromatography with an anti-
ATRIP antibody (175). ATR and ATRIP proteins were separated by SDS-PAGE and 
subjected to mass spectrometry by Jeremy Myers (175). Two phosphorylation sites on 
ATRIP were identified, S224 and S239. ATRIP S224 surrounding peptides contain a 
Cdk2 consensus site S/TPXR/K (274). This peptide is highly conserved across many 
species (Figure 3.1A). It suggests that ATRIP is a potential Cdk2 substrate. Detected with 
a phosphopeptide-specific antibody, phosphorylation of ATRIP on S224 occurs in cells, 
peaks in S phase, and correlates with Cdk2 kinase activity (175). In addition, 
phosphorylation of ATRIP on S224 is sensitive to Roscovitine, a Cdk2 inhibitor, but not 
to any other kinase inhibitor tested (Figure 3.1B).  
To confirm that ATRIP S224 is a substrate of Cdk2, an in vitro kinase assay was 
performed with the purified Cdk2-cyclin A complex (Figure 3.1C). The ATRIP S224A 
mutant exhibits no phosphorylation while phosphorylation of wild type ATRIP is 
indicated by 32P-ATP incorporation (Figure 3.1C, compare lanes 2 and 4). However, the 
ATRIP S239A mutant is phosphorylated to a comparable level to the wild type ATRIP.  
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Figure 3.1. ATRIP S224 is a Cdk2 substrate. (A) Sequence alignment of the 
ATRIP region containing S224 and S239. (B) HeLa cells were treated with the 
following inhibitors for 14 h: roscovitine (25 and 50 µmol/L), U0126 (25 
µmol/L), 10 nmol/L rapamycin (Rap), 20 µmol/L wortmannin (Wort), 10 
µmol/L 5,6-dichlorobenzimidazole riboside (DRB), 10 µmol/L H-7 
dihydrochloride (H-7). Cell lysates were separated by SDS-PAGE and 
immunoblotted with ATRIP P-S224 or ATRIP antibodies. (C) Wild type or 
mutant HA-ATRIP-Flag-ATR complexes were purified from transiently 
transfected HEK293T cells with HA-agarose beads. Kinase reactions were 
done with recombinant Cdk2-cyclin A. This experiment of panel B was done 
by Dr. Jeremy Myers. 
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This suggests that the S224 site is the major substrate of Cdk2-cyclinA while ATRIP 
S239 is phosphorylated in cells (175, 176). In addition, mutation of S224 and S239 to 
alanine does not alter ATRIP interaction with ATR (Figure 3.1C). Taken together, 
ATRIP S224 is phosphorylated by Cdk2 in vitro and in vivo. 
 
The phosphorylation of ATRIP S224 is required for G2-M checkpoint maintenance 
To examine the functional significance of ATRIP S224 phosphorylation, we 
established stable cell lines expressing either HA-ATRIP or the HA-ATRIP S224A 
mutant by retrovirus infection. Both cell lines express equal ATRIP as determined by 
western blot. The percentage of cells expressing ATRIP was determined to be equal by 
immunofluorescence. ATRIP forms DNA damage inducible foci (163). The ATRIP 
S224A mutant has the same ability to form foci in response to IR (data not shown). The 
ATRIP cDNA contains wobble base pair mutations. This property makes them 
insensitive to RNAi mediated depletion when using a specific ATRIP siRNA. 
Transfection of ATRIP siRNA decreases endogenous ATRIP expression at least 90% 
without affecting the expression of exogenous HA-ATRIP (Figure 3.2A).  
When cells are irradiated with UV or IR, ATR is activated. ATR activation 
promotes cell cycle arrest at G2 before entering mitosis through inhibition of Cdk1 
activity (133). ATRIP is required for maintaining the ATR-dependent G2-M checkpoint 
after DNA damage. All three cell lines expressing no cDNA, HA-ATRIP, or HA-ATRIP 
S224A exhibit indistinguishable growth curves, cell cycle profiles, and mitotic indices 
(about 1.7%; 45% after 12 hours incubation in the presence of nocodazole).  Among the 
cells expressing wild type ATRIP, about 2.5% of cells enter mitosis after UV treatment in  
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Figure 3.2. ATRIP S224 is required for ATR-ATRIP-dependent G2-M 
checkpoint responses to DNA damage. (A) U2OS cells expressing siRNA-
resistant cDNA for HA-ATRIP (WT), HA-ATRIP S224A, or no cDNA (Vec) 
were transfected with non-specific (NS) or ATRIP (A4) siRNA. Cells were 
harvested 3 days after transfection and analyzed for ATRIP expression by 
immunoblotting. (B and C) 3 days after transfection with ATRIP siRNA, 
U2OS cells containing ATRIP (WT), ATRIP S224A, or vector were treated 
with 25 J /m2 UV radiation (B) or 4 Gy of IR (C). Nocodazole was added to 
the culture media to trap cells in mitosis. In (B), cells were harvested and fixed 
with Carnoy’s fixative, and mitotic spreads were analyzed 8 hours after 
exposure to UV. The percentage of mitotic cells was calculated based on 
counting at least 600 cells. Bars, SE. In (C), cells were harvested at the 
indicated time points following IR, fixed with ethanol, permeabilized, and 
stained with anti-phospho-histone H3 S10 antibody and propidium iodide. The 
percentage of mitotic cells was determined by flow cytometry. Runxiang Zhao 
contributed significant efforts in this figure. 
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8 hours (Figure 3.2B). However, among the cells without ATRIP, 8% of cells enter 
mitosis after UV treatment. In the cells expressing the ATRIP S224A mutant, about 7% 
of cells enter mitosis after UV treatment. This suggests that a G2-M checkpoint defect 
occurred in the ATRIP mutant cell line. The level of this defect is nearly the same as the 
ATRIP deficiency. In addition, the mutant cell line exhibits a G2-M checkpoint defect 
after IR treatment. In the early time point (2 hours after IR), there is no significant 
difference among the 3 cell lines. However, at the time point of 8 hours and 16 hours, 
there are more cells expressing the ATRIP mutant entered mitosis compared to the cells 
expressing wild type ATRIP (Figure 3.2C). It suggests a G2-M checkpoint maintenance 
defect with the ATRIP S224A mutant. 
  
CINP is an ATRIP interacting protein 
ATRIP is associated with ATR constitutively (163). We also tried another 
approach to study the mechanism of ATR activation regulated by ATRIP by identifying 
ATRIP interacting proteins. A yeast-two hybrid screen was performed by Gloria Glick 
with full length ATRIP as the bait and a B cell cDNA library was screened. ATRIP 
interacts with ATRIP in the yeast two hybrid screen. It suggests that ATRIP forms 
oligomers. This is consistent with our previous report (168).  
CINP (gene accession number: NM_032630) was identified as a novel ATRIP 
interacting protein in yeast two hybrid screen. To validate the ATRIP interaction with 
CINP, co-immunoprecipitation was performed. After transient transfection of HEK293T 
cells with Flag-ATR and HA-CINP or Flag-ATRIP and HA-CINP, total cell lysates were 
used for immunoprecipitation with anti-Flag beads. HA-CINP can be co-precipitated with 
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Flag-ATR and Flag-ATRIP (Figure 3.3A, top and middle panels). Reciprocally, ATR and 
ATRIP can be co-precipitated with CINP as well (Figure 3.3A, bottom panel). The data 
here confirmed that ectopically expressed CINP can interact with the ATR-ATRIP 
complex. Furthermore, the interaction between CINP and ATR-ATRIP is not altered after 
cells are treated with DNA damage agents or replication inhibitors (Figure 3.3B).  
In addition to detecting the exogenous level of protein interaction, Courtney 
Lovejoy and Gloria Glick performed co-immunoprecipitation with an anti-CINP antibody 
for endogenous CINP. Both ATR and ATRIP are co-precipitated with CINP (Figure 3.3C 
and 3.3D). These data verified that CINP interacts with ATRIP-ATR complex in a 
physiological condition.  
 
CINP interacts with ATRIP coiled-coil domain 
 To map the specific regions of ATRIP involved in its interaction with CINP, we 
performed a yeast two-hybrid screen as described (168). We fused full length CINP to the 
GAL4 DNA binding domain to screen a library containing random ATRIP fragments 
fused to the GAL4 activation domain. The interaction positive fragments were recovered 
and sequenced. The protein sequences encoded by recovered ATRIP fragments are 
aligned (Figure 3.4A). Among these ATRIP fragments, the common region contains 
amino acids 118 to 156 of ATRIP, which is also the N-terminal half of the predicted 
ATRIP coiled-coil domain (Figure 3.4A). 
I validated the yeast two hybrid results by co-immunoprecipitation. HA tagged 
ATRIP or the ATRIP fragments were co-expressed with Flag-CINP in HEK293T cells. 
Immunoprecipitation was performed with anti-Flag agarose beads. The ATRIP fragment 
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Figure 3.3. CINP interacts with ATRIP-ATR complex. (A) HA-CINP and 
Flag-ATR (top panel), or HA-CINP and Flag-ATRIP (middle panel), or 
Flag-CINP and HA-ATRIP (bottom panel) were co-expressed in HEK293T 
cells as indicated. Immunoprecipitation was performed with anti-Flag beads. 
Input (TCL) and precipitated proteins were detected by immunoblotting with 
anti-Flag and anti-HA antibodies. (B) Flag-ATR, Myc-ATRIP and HA-CINP 
were co-expressed in HEK293T cells. Cells were mock treated (NT), treated 
with UV 50 J/m2 followed by 2 hours incubation, or IR 5 Gy followed by 1 
hour incubation before harvesting. IP was performed with anti-Flag beads. 
Input (TCL) and precipitated proteins were detected by immunoblotting with 
anti-Flag, anti-Myc, and anti-HA antibodies. (C) Endogenous CINP was 
immnuoprecipitated with anti-CINP antibody from HeLa cell total cell 
lysate. Precipitated proteins were detected with anti-ATR and anti-CINP 
antibodies. (D) Endogenous ATRIP was immunoprecipitated from 
HEK293T cell nuclear extracts. Precipitated proteins were detected with anti-
CINP, anti-ATR, and anti-ATRIP antibodies. The experiments for panels C 
and D were performed by Courtney Lovejoy and Gloria Glick. 
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Figure 3.4. CINP interacts with the coiled-coil domain of ATRIP. (A) A 
schematic diagram of ATRIP indicating the known functional domains 
including the nuclear localization signal (NLS), checkpoint recruitment 
domain (CRD), coiled-coil domain (CC), TopBP1-binding domain 
(TopBP1), ATR-binding domain (ATR), and phosphorylation sites. ATRIP 
fragments found to interact with full-length CINP in a yeast two-hybrid 
screen were aligned with their starting and ending sites. (B) Flag-CINP was 
co-expressed with HA-ATRIP or HA-ATRIP mutants including 181-435 
residues deletion, 112-225 residues deletion, and the coiled-coil domain 
(112-225) replaced with GCN4 coiled-coil domain in HEK293T cells. 
Immunoprecipitation was performed with anti-Flag beads. The precipitated 
proteins were detected by immunoblotting with anti-HA and anti-Flag 
antibodies. This experiment was performed by Dr. David Cortez. 
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lacking residues 181-435 co-precipitated with CINP efficiently as wild type ATRIP 
(Figure 3.4B). However, the ATRIP fragment lacking the coiled-coil domain (lacking 
residues 112-225) can not be detected in the Flag-CINP precipitates (Figure 3.4B). 
Although the ATRIP mutant with a GCN4 coiled-coil domain substitution has been 
shown able to oligomerize (168), this mutant was not detected in the CINP precipitates 
(Figure 3.4B). 
 
CINP regulates ATR signaling 
 ATR functions in checkpoint maintenance in part through activating Chk1 (97, 
219). Chk1 phosphorylation on S345 and S317 by ATR after DNA damage is required 
for Chk1 function in arresting the cell cycle (97, 219-221). ATRIP is required for ATR-
dependent Chk1 phosphorylation and G2-M checkpoint maintenance (163). Therefore, I 
examined whether CINP functions in regulating Chk1 phosphorylation. CINP was 
depleted in cells by siRNA transfection. Chk1 phosphorylation was determined by 
immunoblotting with anti-phosphopeptide antibodies to Chk1, p-Chk1 S345 and p-Chk1 
S317. After DNA damage treatments including UV and IR, the CINP depleted cells 
exhibit decreased Chk1 phosphorylation on S345 and S317 compared to the cells 
transfected with non-targeting siRNA (Figure 3.5A). Phosphorylation of Chk1 on S317 
was reduced 30% and 50% in CINP depleted cells compared to non-specific siRNA 
transfected cells upon UV and IR treatment respectively (Figure 3.5A). ATR activation 
occurs in S after DNA damage or replication stress during the cell cycle. At the time 
point I assayed for Chk1 phosphorylation, the CINP depleted cells show indistinguishable 
cell cycle profile as non-specific siRNA transfected cells (data not shown). 
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Figure 3.5. CINP functions in ATR signaling. (A) hTERT-RPE cells were 
transfected with non-specific siRNA (NS) or siRNA targeting CINP (CINP-
1). 3 days after transfection, cells were untreated (NT), treated UV 50 J/m2 
followed by 2 hours incubation, or treated with IR 5 Gy followed by 1 hour 
incubation. Phosphorylation of Chk1 on S345 and S317 were examined (top 
panel). The ratio of phosphorylated Chk1 S317 to Chk1 were quantitated 
with NIH image and normalized to non-specific siRNA transfected cells with 
UV treatment. (B) U2OS cells were transfected with non-specific siRNA 
(NS), siRNA targeting CINP (CINP-1 and CINP-4), or siRNA targeting 
ATRIP. 3 days after transfection, cells were untreated (NT), treated with UV 
25 J/m2 followed by 8 hours incubation in the presence of 1 µg/ml 
Nocodazole, or treated with IR 4 Gy followed by 8 hours incubation in the 
presence of 1 µg/ml Nocodazole. Cells were harvested and fixed with 
Carnoy’s fixative, and mitotic spreads were analyzed. The percentage of 
mitotic cells was calculated based on counting 300 cells. Bars, SE. 
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Furthermore, I examined whether CINP is required for ATR-dependent G2-M 
checkpoint maintenance. Cells were damaged with UV or IR and then incubated in the 
presence of nocodazole to trap cells in mitosis. The percentage of mitotic cells was 
determined. In cells with ATRIP depletion, more cells entered mitosis after DNA damage 
treatment than cells transfected with non-specific siRNA (Figure 3.5B). This indicates 
that the maintenance of the G2-M checkpoint is compromised when ATRIP is depleted. 
A comparable percentage of cells entered mitosis after DNA damage treatment in CINP 
depleted cells and ATRIP depleted cells. Thus, CINP functions in ATR signaling and 
maintaining the G2-M checkpoint.   
 
CINP regulates ATRIP S224 phosphorylation  
 CINP was identified as a Cdk2 interacting protein (275). ATRIP S224 is 
phosphorylated by Cdk2. Both depletion of CINP or mutation of ATRIP S224 to alanine 
compromise ATR-dependent G2-M checkpoint maintenance. Therefore, I hypothesized 
that CINP functions in regulation of ATR signaling through regulating the 
phosphorylation of ATRIP S224. I examined phosphorylation of ATRIP S224 when 
CINP is depleted from cells (Figure 3.6A). ATRIP S224 phosphorylation is barely 
detected in RPE cells when they are arrested in G0 (Figure 3.6A). This is consistent with 
our previous report (175). Cells were released into S phase, and phosporylation of ATRIP 
S224 was elevated (Figure 3.6A). The level of phosphorylation on ATRIP S224 was 
decreased 51% and 58% in cells where CINP was depleted by transfection with two 
different siRNA oligos targeting CINP (Figure 3.6A). However, depletion of CINP leads 
to indistinguishable cell cycle profiles (Figure 3.6B). 
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Figure 3.6. CINP regulates phosphorylation of ATRIP S224. hTERT-RPE 
cells stably expressing HA-ATRIP were established by retrovirus infection. Cells 
were transfected with non-specific siRNA or CINP siRNA (CINP-1 and CINP-
6) followed by plating cells at high density to arrest in G0 for 24 hours. 3 days 
after siRNA transfection, cells were released by splitting to allow cells back to 
cell cycle for 24 hours. (A) ATRIP S224 phosphorylation and total ATRIP were 
examined (top panel) and quantitated by Odyssey system. The ratio of 
phosphorylated ATRIP S224 to total ATRIP were calculated and normalized to 
the released non-specific siRNA transfected cells (bottom panel). Error Bars 
stand for standard error. (B) cells in parallel with cells in (A) were fixed and 
analyzed for DNA content by flow-cytometry after PI staining. 
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Depletion of CINP induces DNA damage 
While I characterized the function of CINP, a screen for loss of gene function 
inducing DNA damage responses was conducted by Courtney Lovejoy. The readout is 
phosphorylation of KAP-1 (KRAB domain association protein 1) on S824. KAP-1 S824 
is a substrate of ATM, and phosphorylation of KAP-1 can be detected as a pan-nuclear 
staining by immunofluorescence when DNA double strand breaks occur (276, 277). 
Courtney Lovejoy found that depletion of CINP causes phosphorylation of KAP-1 in by 
immunofluorescence in the screen (data not shown). Histone proteins H2AX are 
phosphorylated and form foci when DNA damage occurs in cells (278, 279). CINP 
depletion also leads to γH2AX foci formation, which also suggests that DNA damage 
response is activated in CINP depleted cells (Figure 3.7A). 
We further examined the DNA damage response induced by CINP depletion with 
other markers by immunoblotting. P53 is phosphorylated upon induction of DNA damage 
by PI-3 kinases including DNA-PK, ATM, and ATR (98, 99, 101, 102). While depletion 
of CINP does not cause detectable Chk1 or Chk2 phosphorylation (data not shown), 
depletion of CINP leads to a mild level of p53 phosphorylation compared to the level of 
p53 phosphorylation induced by DNA damage (Figure 3.7B). Thus, consistent with the 
result that depletion of CINP leads to phosphorylation of KAP-1 and γH2AX foci 
formation, CINP is required to maintain the genome integrity. 
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 Figure 3.7. Depletion of CINP causes DNA damage response in cells. 
(A) U2OS cells were transfected with non-specific siRNA (NS), siRNA 
targeting Chk1 (Chk1-1 and Chk1-2), or siRNA targeting CINP (CINP-1 
and CINP-3). 2 days after transfection, cells were cultured on cover slip 
for 24 hours. Cells on cover slip were analyzed by immunofluorescence 
microscopy with anti-phospho-H2AX antibody. γ-H2AX foci were 
counted for 100 cells and repeated for 3 times each sample. Bars, SE. 
Numbers on top of the bars are p values calculated with unpaired, two-
tailed t test with the sample of NS. (B) hTERT-RPE cells were 
transfected with non-specific siRNA (NS) or siRNA targeting CINP 
(CINP-1 and CINP-3). 42 hours after transfection, cells were untreated 
(NT), treated UV 50 J/m2 followed by 2 hours incubation, or treated with 
IR 5 Gy followed by 1 hour incubation. Phosphorylation of p53 on S15 
was examined by immunoblotting. MCM2 levels were determined and 
served as loading control. The experiment of panel A was performed by 
Courtney Lovejoy. 
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Discussion 
ATRIP interacts with ATR constitutively (163). The ATR-ATRIP complex is 
required for ATR function in many aspects including the localization of ATR to sites of 
DNA damage and enhancement of ATR kinase activity (137, 160). Here we reported that 
ATRIP regulates ATR function by additional mechanisms. First, phosphorylation of 
ATRIP on S224 is required for ATR-dependent G2-M checkpoint maintenance (Figure 
3.2). Second, ATRIP interacting protein, CINP regulates ATR signaling and its function 
in G2-M checkpoint maintenance (Figure 3.5). Furthermore, CINP also regulates 
phosphorylation of ATRIP on S224 (Figure 3.6).     
Phosphorylation is a common mechanism by which PIKKs regulate the DNA 
damage response in cells. We have identified two phosphorylation sites on ATRIP, S224 
and S239. ATRIP S224 phosphorylation is not induced upon DNA damage or replication 
stress (175). Instead, it correlates with cyclin A level during the cell cycle. It suggests this 
phosphorylation is not a rapid regulation to turn on or off the ATR signaling pathway. 
The ATRIP S224 phosphorylation may be important to potentiate specific ATR activities.  
We also found ATRIP S239 is phosphorylated in the mass spectrometry study. 
Consistent with our result, phosphorylation of ATRIP S239 was identified with anti-
phospho-peptide antibodies and is required for G2-M checkpoint maintenance after DNA 
damage (176). Moreover, it is reported that phosphorylation of ATRIP S239 is required 
for interaction with the BRCT (BRCA1 COOH-terminal) repeats of BRCA1 (176). 
BRCA1 also functions in G2-M checkpoint maintenance (280). This suggests that 
phosphorylation of ATRIP S239 contributes to the G2-M checkpoint maintenance 
through interaction with BRCA1 (176). The ATRIP S224A mutant and the S239A 
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mutant form foci efficiently after DNA damage (175, 176). Consistent with this, these 
mutants have normal ATRIP functions in oligomerization, interaction with ATR, and 
supporting ATR kinase activity stimulated by TopBP1 in vitro (data not shown). It is 
possible that both ATRIP phosphorylation on S224 and S239 serve as protein interaction 
binding sites to facilitate the G2-M checkpoint maintenance. BRCTs domains of BRCA1 
tend to bind phospho-peptides (281, 282). It is possible that both phosphorylation on 
S224 and S239 contribute to ATRIP interaction with other proteins including BRCA1. 
This could be the mechanism by which ATRIP S224 phosphorylation regulates ATR-
dependent checkpoints. 
While ATRIP S224 is the major substrate of the Cdk2-cyclin A complex in the in 
vitro kinase assay (Figure 3.1), ATRIP S239 could be a Cdk2 substrate in vivo. Plus Cdk2 
can function as a kinase with either cyclin E or cyclin A. ATRIP S239 phosphorylation 
occurs in a later time point when cell cycle is arrested after DNA damage (176). Whether 
ATRIP S239 phosphorylation is sensitive to Cdk2 inhibitor is undetermined.  
CINP is a novel ATRIP interacting protein identified by yeast-two hybrid screen. 
This interaction was confirmed by co-immunoprecipitation with endogenous and 
exogenous proteins (Figure 3.3). However, the interaction between CINP and ATRIP is 
much less efficient with endogenous levels of protein than the interaction with ectopically 
expressed level of proteins (compare Figure 3.3A and 3.3C). There are several 
possibilities. One, endogenous CINP abundance is very low in cells. Two, a better anti-
CINP antibody is required to perform the co-immunoprecipitation. Three, the interaction 
between CINP and ATRIP is very dynamic. We were unsuccessful to detect CINP 
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localization by immunofluorescence with current antibodies. Therefore, we were not able 
to detect CINP co-localization with ATRIP by immunofluorescence.    
CINP interacts with the ATRIP coiled-coil domain (Figure 3.4). It is unclear 
which region on CINP is involved in the interaction with ATRIP. The CINP protein 
sequence predicts a coiled-coil domain in the N-terminal region containing residues 25-
125 by the coiled-coil domain prediction program. Coiled-coil domains are often 
involved in protein oligomerization (283). It is likely that ATRIP interacts with CINP 
through their coiled-coil domains. The ATRIP mutant forms oligomers but fails to 
facilitate Chk1 phosphorylation after DNA damage when the coiled-coil domain is 
replaced with the GCN4 coiled-coil domain (168). This ATRIP mutant interaction with 
CINP is compromised (Figure 3.8). This suggests that the CINP interaction with ATRIP 
is distinct from ATRIP oligomerization. Defected binding ability to CINP may in part 
explain why the ATRIP mutant with GCN4 coiled-coil domain replacement leads to a 
Chk1 phosphorylation defect.  
CINP regulates phosphorylation of ATRIP S224 (Figure 3.6). It is not known 
whether this regulation is direct. CINP was identified as a Cdk2 interacting protein by a 
yeast two-hybrid assay (275). Because phosphorylation of ATRIP S224 is regulated by 
Cdk2-cyclin A directly, CINP may function as a bridge between Cdk2 and ATRIP 
(Figure 3.9). This can be tested by examining ATRIP interaction with Cdk2 in the 
absence and presence of CINP. Also it is possible that CINP plays a role to protect the 
phosphorylation of ATRIP S224 from phosphatases. In this case, the phosphatase 
remains to be identified. 
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Figure 3.8. Summary of ATRIP functional domains. Top panel, 
full length ATRIP highlighted with nuclear localization signal 
(NLS), checkpoint recruit domain (CRD), phosphorylation sites (p, 
on S68, S72, S224, and S239), coiled-coil domain (CC), TopBP1 
binding domain (TopBP1), and ATR binding domain (ATR). 
Bottom panel, summary of loss of function in ATRIP mutants 
including the coiled-coil domain deletion mutant and the coiled-coil 
domain replaced with GCN4 coiled-coil domain mutant [this study 
and reference (168)]. Localization means ATRIP foci formation 
after DNA damage. 
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Figure 3.9. The current testing model of CINP dependent 
ATR-Chk1 signaling pathway. We hypothesize that CINP 
functions as a bridge between ATR-ATRIP complex and 
Cdk2. The ATRIP S224 is required for Chk1 phosphorylation 
and G2-M checkpoint maintenance after DNA damage. 
 
 104 
Cyclin-dependent kinases are major targets of the ATR/ATM-dependent 
checkpoint response to DNA damage. Inhibition of Cdk activities promote cell cycle 
arrest and therefore provide time for cells to repair the damaged DNA. Meanwhile, more 
and more evidence suggests that the cell cycle and Cdk activity also regulate many 
aspects of cellular response to DNA damage (284, 285). First, ATR is activated primarily 
in S-phase. A long stretch of single-stranded DNA coated by RPA is the main upstream 
signal for ATR activation. This RPA-ssDNA structure can be generated during DNA 
lesion processing (233-236, 284, 286, 287) or the uncoupling of DNA helicase and 
polymerase activities at DNA replication forks (139, 266). Cdk2 activity is required for 
both situations. Second, ATR activation after double strand breaks requires the ends to be 
resected into single stranded DNA. This process depends on Cdk activity (233, 236, 286). 
Third, inhibition of Cdk2 activity leads to reduced Chk1 expression, and Chk1 is a 
substrate of ATR (287). Here we found that ATRIP S224 phosphorylation is Cdk2 
dependent, and this phosphorylation is required for G2-M checkpoint maintenance after 
DNA damage (175). Thus, Cdk2 regulates checkpoint signaling and also is inhibited by 
cell cycle checkpoints. 
CINP was identified as a Cdk2 interacting protein by a yeast two-hybrid assay. 
Moreover, CINP is phosphorylated by the Cdc7-Dbf4 complex but not the Cdk2-cyclin E 
complex in vitro (275). CINP is an in vitro substrate of Cdk2-cyclin A (data not shown). 
The CINP peptide TLGTV(p)TPR was detected to be phosphorylated in a mass 
spectrometry analysis (288). The responsible kinase for CINP in cells needs to be 
determined. The CINP T10 surrounding residues (TPRK) indicate a Cdk consensus site 
(274). Moreover, CINP contains the specific cyclin-binding motif (Cy motif) RXL (RAL, 
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210-212) (289). This is a property for proteins to interact with cyclins, which also 
suggests that CINP is a substrate candidate of Cdk2. While no CINP orthologue in yeast 
has been discovered, the TPRK peptide is conserved in mice, rats, and xenopus. Further 
experiments are required to confirm CINP phosphorylation and characterize its function.  
I show here that CINP is required for ATR signaling after DNA damage. The 
checkpoint maintenance defect in cells where CINP is depleted is comparable to cells 
where ATRIP is depleted (Figure 3.5). In contrast, CINP depletion only reduces ATRIP 
phosphorylation on S224 about 45%. Thus, in addition to ATRIP S224 phosphorylation, 
other mechanisms by which CINP regulates G2-M checkpoint maintenance remain 
unclear. The CINP mutant lacking ATRIP interaction domain will suggest whether the 
regulation of checkpoint maintenance by CINP is ATRIP-dependent. We are in the 
process to identify proteins interacting with CINP. The results will lead us a direction to 
study how the checkpoint maintenance is regulated by CINP.  
CINP has additional functions other than G2-M checkpoint maintenance. 
Depletion of CINP causes a DNA damage response but not as severe as depletion of 
Chk1 (Figure 3.7A). In the loss of function screen, Courtney Lovejoy also found that 
depletion of CINP affects cell proliferation and sensitizes cells to hydroxyurea (HU, a 
replication inhibitor by depletion of the dNTP pool). It suggests that CINP may function 
in regulation of DNA replication. ATR and ATM function in regulation of DNA 
replication by controlling DNA replication origin firing (138). CINP interaction with 
ATRIP may also contribute to the regulation of origin firing. Consistent with this, CINP 
is speculated to play a role in DNA replication based on reported interactions with Cdk2, 
CDC7, ORC and MCM complexes (275). 
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In summary, we characterized additional mechanisms by which ATRIP regulates 
ATR function. Phosphorylation of ATRIP S224 regulates ATR function in G2-M 
checkpoint maintenance. We found that CINP is a novel ATRIP interacting protein 
functioning in G2-M checkpoint maintenance after DNA damage and is required for 
genome stability. This is the first report for CINP function to my knowledge. Our data 
suggest that CINP functions in G2-M checkpoint maintenance partially through 
regulating ATRIP S224 phosphorylation. Thus, CINP functions in the maintenance of 
checkpoints and genome stability. 
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CHAPTER IV 
 
THE BASIC CLEFT OF RPA70N BINDS MULTIPLE CHECKPOINT 
PROTEINS, INCLUDES RAD9, TO REGULATE ATR SIGNALING2 
 
Summary 
ATR kinase activation requires the recruitment of the ATR-ATRIP and RAD9-
HUS1-RAD1 (9-1-1) checkpoint complexes to sites of DNA damage or replication stress. 
Replication Protein A (RPA) bound to single-stranded DNA is at least part of the 
molecular recognition element that recruits these checkpoint complexes. We have found 
that the basic cleft of the RPA70 N-terminal oligonucleotide-oligosaccharide fold (OB-
fold) domain is a key determinant of checkpoint activation. This protein-protein 
interaction surface is able to bind several checkpoint proteins, including ATRIP, RAD9, 
and MRE11. RAD9 binding to RPA is mediated by an acidic peptide within the C-
terminal RAD9 tail that has sequence similarity to the primary RPA-binding surface in 
the checkpoint recruitment domain (CRD) of ATRIP. Mutation of the RAD9 CRD 
impairs its localization to sites of DNA damage or replication stress without perturbing 
its ability to form the 9-1-1 complex or bind the ATR activator TopBP1. Disruption of 
the RAD9-RPA interaction also impairs ATR signaling to CHK1 and causes 
hypersensitivity to both DNA damage and replication stress. Thus, the basic cleft of the 
RPA70 N-terminal OB-fold domain binds multiple checkpoint proteins, including RAD9, 
to promote ATR signaling. 
 
                                                
2 This chapter has been previously published in ref 290. Xu, X., et al. (2008) The basic cleft of 
RPA70N binds multiple checkpoint proteins, including RAD9, to regulate ATR signaling. Mol Cell Biol, 
28, 7345-53.  
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Introduction 
The DNA damage response (DDR) coordinates cell cycle transitions, DNA 
replication, DNA repair and apoptosis. The major regulators of the DDR are the 
phosphoinositide-3-kinase-related protein kinases ATM (ataxia-telangiectasia mutated) 
and ATR (ATM and Rad3 related). ATR is activated during every S-phase to regulate the 
firing of replication origins, the repair of damaged replication forks and to prevent the 
premature onset of mitosis (133). 
ATR is activated in response to many types of DNA lesions including double 
strand breaks (DSB), base adducts, cross-links, as well as replication stress. In most cases 
these lesions activate ATR as a consequence of tracts of single-stranded DNA (ss-DNA) 
that are formed during lesion processing (233-236) or uncoupling of helicase and 
polymerase activities at replication forks that encounter the lesion (139). Most forms of 
ss-DNA in the cell, including the ss-DNA formed during DNA replication and DNA 
repair, are rapidly coated by replication protein A (RPA) (36). Depletion of RPA from 
Xenopus egg extracts reduces the association of ATR with chromatin (136), and RPA-
coated ss-DNA (hereafter RPA-ssDNA) is important to localize ATR to sites of DNA 
damage in both human and budding yeast systems (137).  
Although RPA-coated ssDNA may be sufficient for localizing the ATR-ATRIP 
complex, it is not sufficient for ATR activation (140, 291, 292). ATR signaling is 
dependent on co-localization of the ATR-ATRIP complex with the 9-1-1 complex, a 
hetero-trimeric ring-shaped molecule related in structure and sequence to the replicative 
sliding clamp, PCNA (244). 
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Like PCNA, the 9-1-1 complex is loaded onto primer-template junctions in an 
ATP-dependent reaction that involves the RAD17 damage-specific clamp loader (161, 
190, 196). Loading of the 9-1-1 complex occurs at a DNA end that is adjacent to a stretch 
of RPA-coated ssDNA. The presence of RPA is critical for this reaction and imparts 
specificity in loading, creating a preference for a 5'- rather than a 3'-primer end (159, 
161). The 9-1-1 complex concentrates an ATR-activator, TopBP1, at sites of DNA 
damage or replication stress. TopBP1 stimulates ATR kinase activity (217) by interacting 
with both a PIKK regulatory domain in ATR and the ATR-interacting protein ATRIP 
(163, 218).  
ATR recognition of RPA-coated ssDNA depends upon ATRIP (137). 
Biochemical studies indicate that ATRIP binds RPA directly via evolutionarily conserved 
binding surfaces (151). The primary interaction involves an acidic alpha helix within a 
checkpoint recruitment domain (CRD) of ATRIP that binds in the basic cleft of the N-
terminal OB-fold domain of the large RPA subunit, (RPA70N) (151). Deleting or 
mutating the ATRIP CRD abolishes its interaction with RPA70 and prevents ATR-
ATRIP complexes from being efficiently retained at sites of DNA damage or stalled 
replication forks (160). Remarkably, mutations within the ATRIP CRD or even deletion 
of the entire CRD do not cause a large ATR-checkpoint signaling defect in human, 
Xenopus or budding yeast systems (151, 160, 293). This result is surprising given that the 
current model of ATR activation postulates that the ATRIP-RPA interaction should be 
essential for ATR signaling. 
In this report, we further investigated the role of RPA in checkpoint signaling.  
First, the consequences of mutating the ATRIP binding surface on RPA70N were 
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analyzed.  As expected, these mutations impair ATRIP binding. However, in contrast to 
the ATRIP CRD mutations, the RPA binding surface mutations cause a significant defect 
in ATR-dependent signaling to CHK1. To reconcile these data, we hypothesized that 
additional ATR regulatory proteins may bind to RPA using the same binding surface.  
We found that at least three checkpoint proteins bind to RPA using the same binding cleft 
within the RPA70N OB-fold domain.  Notably, the C-terminal tail of RAD9 binds in the 
cleft. We show this interaction is important for RAD9 recruitment to sites of DNA 
damage and stalled replication forks, and is important for ATR signaling. Thus, RPA-
ssDNA is a common signal within the DNA damage response to regulate multiple 
checkpoint complexes. 
 
Materials and Methods 
NMR analysis 
Nuclear magnetic resonance (NMR) experiments were performed at 25 °C using 
Bruker AVANCE 500 MHz or 600 MHz NMR spectrometers equipped with a 5 mm 
single axis z-gradient Cryoprobe. Two-dimensional, gradient-enhanced 15N-1H 
heteronuclear single-quantum coherence (HSQC) spectra were recorded with 1,024 
complex points in the 1H dimension and 96 complex points in 15N dimension. 1H and 15N 
backbone NMR assignments for RPA70N were kindly provided by Cheryl Arrowsmith 
(Ontario Cancer Institute, Toronto, Canada). 15N-enriched RPA70N NMR samples were 
prepared in a buffer containing 5 mM DTT, 50 mM NaCl, 20 mM Tris-d11, and 5% D2O 
at pH 7.4 at a protein concentration of ~100 µM. ATRIP (DFTADDLEELDTLAD), 
MRE11 (AFSADDLMSIDLAEQ), and RAD9 (DFANDDIDSYMIAME) peptides were 
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purchased (Sigma) and purified by HPLC. Peptides were added at a four- to six-fold 
molar excess to maximize the population of peptide-bound RPA70N molecules. All 
spectra were processed with TOPSPIN v1.3 (Bruker, Billerica, MA) and analyzed with 
Sparky v3.1 (University of California, San Francisco, CA).  
 
Cell culture 
HEK293T, HeLa, and U2OS cells were cultured in Dulbecco modified Eagle 
medium (DMEM, Invitrogen) supplemented with 7.5% fetal bovine serum at 37°C in 5% 
CO2. RAD9+/+ and RAD9-/- mouse embryonic stem (ES) cells were kindly provided by Dr. 
Howard Lieberman and cultured as described (185). RAD9-/- ES cells were transfected 
with Lipofectamine2000 (Invitrogen), and stable clones were selected in medium 
containing G418 (0.2 mg/ml). U2OS cells expressing RAD9 or RAD9-crd were 
established by retroviral infection and puromycin selection. HeLa cells were transfected 
with Lipofectamine2000 (Invitrogen) according to the manufacture’s instructions. 
 
Nuclear extracts, in vitro translation, chromatin lysate, and cell lysate preparation 
Nuclear extracts were prepared as described in Chapter III and reference (218). 
RAD9 and RAD9-crd proteins were in vitro translated with TNT Quick Coupled 
Transcription/Translation System (Promega). Chromatin lysates were prepared by 
sonicating nuclei resuspended in immunoprecipitation buffer (0.3% CHAPS {3-[(3-
cholamidopropyl)-dimethylammonio]-1-propanesulfonate}, 20 mM HEPES, pH 7.9, and 
150 mM NaCl supplemented with protease and phosphatase inhibitors [5 µg/ml aprotinin, 
5 µg/ml leupeptin, 1 mM NaF, 20 mM β-glycerol phosphate, 1 mM sodium vanadate, 1 
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mM DTT, 1 mM PMSF]). Cell lysates were prepared using Igepal lysis buffer (1% Igepal 
CA-630, 50 mM Tris, pH 8.0, and 200 mM NaCl supplemented with protease and 
phosphatase inhibitors). 
 
Antibodies 
Antibodies were purchased from Covance (HA.11), Oncogene Research Products 
(RPA70), Cell Signaling Technology (CHK1 P-S345 and CHK1 P-S317), Santa Cruz 
Biotechnology (CHK1 and RAD1), Bethyl Laboratories (KAP1 P-S824, RAD17, and 
TopBP1), Chemicon/Millipore (GAPDH), and Abgent (RAD9 P-S272 and RAD9 P-
S387).  
 
GST pull down assays 
Recombinant GST-tagged RPA70N proteins were purified from E. coli with 
glutathione sepharose 4B beads according to the manufacturers instructions (GE 
Healthcare). ATRIP1-217 and ATRIP-crd (D58K/D59K)1-217 proteins were also 
purified with glutathione sepharose 4B beads followed by cleavage with PreScission 
protease (GE Healthcare). Nuclear extracts were incubated with the GST-tagged proteins 
bound to beads overnight at 4°C. Beads were washed two times in wash buffer 1 (25 mM 
Tris, pH 8.0, 25 mM NaCl, 0.1 mM EDTA, 10% Glycerol, and 0.25% Trion x-100 
supplemented with protease and phosphatase inhibitors) and once in wash buffer 2 (25 
mM Tris, pH 8.0, 50 mM NaCl, 0.1 mM EDTA, 5% Glycerol, and 0.5% Trion X-100 
supplemented with protease and phosphatase inhibitors). Proteins were eluted with SDS 
sample buffer and separated by SDS-PAGE prior to immunoblotting. 
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DNA constructs and siRNA oligo nucleotides 
Site-directed mutagenesis was performed using QuickChange (Stratagene). All 
constructs generated using PCR were confirmed by sequencing. The siRNA targeting 
RPA70 (5'-AACACUCUAUCCUCUUUCAUG) was purchased from Dharmacon, Inc. 
         
DNA content analysis 
Harvested cells were fixed in ethanol, stained with propidium iodide, and 
analyzed on a BD Biosciences FACSCalibur.  
 
Immunofluorescence  
Cells were cultured on a glass cover slip, fixed with paraformaldehyde, and 
processed as described (294) except using anti-HA primary antibody and FITC-
conjugated goat anti-mouse secondary antibody. Cells were imaged with a Zeiss 
Axioplan microscope equipped with a Zeiss camera and software.  
 
Immunoprecipitation 
Nuclear extracts or chromatin lysates expressing HA-RAD9 or HA-RAD9-crd 
were incubated with anti-HA agarose beads (Sigma). Immunoprecipitates were washed 
three times in TGN buffer (50 mM Tris, pH8.0, 150 mM NaCl, 10% glycerol, and 1% 
Tween 20 supplemented with protease inhibitors).  
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Cell survival assays 
ES cells were plated on gelatinized 6-well dishes and treated with 10 mM 
hydroxyurea (HU) for 12 hours or UV-irradiated (10 J/m2). Surviving cells were stained 
with methylene blue seven days later. Colonies were counted and survival was calculated 
as the percentage of colonies in the treated compared to untreated dishes.  
 
Results 
The RPA70N domain is a checkpoint signaling module  
Previous studies did not identify an ATR signaling defect when the primary RPA 
binding surface within ATRIP is mutated (160). Yet, multiple lines of investigation 
indicate that RPA is a critical regulator of ATR signaling (133). In an attempt to 
understand this discrepancy, we mutated the primary ATRIP binding surface within the 
N-terminal OB-fold domain of RPA70. Based on a computational model of the 
interacting surfaces (151), we predicted that a double charge reversal mutation 
(R41E/R43E) within the basic cleft of the OB-fold would abolish the ATRIP interaction. 
As expected, the RPA70 R41E/R43E mutant no longer binds ATRIP (Figure 4.1A). 
Biophysical characterization of the RPA70N mutant was performed to verify that the 
structural integrity and stability of the domain was retained and therefore any observed 
effect in functional assays is due only to alterations in the binding surface. 
To test the functional consequences of this RPA mutation, HeLa cells were co-
transfected with siRNA targeting RPA70 and vectors encoding siRNA-resistant wild-type 
or mutant RPA70 proteins. Silencing RPA70 causes a reduction in the phosphorylation of 
the ATR-substrate CHK1 in response to ultraviolet (UV) radiation (Figure 4.1B, compare 
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Figure 4.1. The basic cleft of RPA70N is required for ATR-Chk1 activation.  
(A) Nuclear extracts from HEK293 cells expressing HA-ATRIP were incubated 
with GST, GST-RPA70N, or GST-RPA70N R41E/R43E proteins bound to 
glutathione beads. Proteins bound to the beads were eluted, separated by SDS-
PAGE and immunoblotted with anti-HA antibody to detect ATRIP or stained 
with coomassie blue to detect GST proteins (CB).  (B-D) HeLa cells were 
transfected with RPA70 siRNA or non-targeting (NT) siRNA as indicated.  In 
addition, cells were co-transfected with expression vectors encoding siRNA-
resistant wild-type RPA70, RPA70 R41E/R43E, or an empty vector control. (B) 
Transfected cells were left untreated (-) or UV-irradiated (50J/m2). Two hours 
after irradiation, cell lysates were separated by SDS-PAGE and immunoblotted 
with antibodies to RPA70, CHK1-P-S317, and total CHK1 antibodies. 
Quantitations of phospho-CHK1 and CHK1 were measured by infrared imaging 
system (Odyssey) and the ratios of phospho-CHK1 to CHK1 were normalized to 
the sample of cells transfected with empty vector and RPA70 siRNA after DNA 
damage. (C) The percentage of successfully transfected cells in the population 
with an activated DNA damage response (in the absence of an added genotoxic 
agent) was determined by staining with the phospho-peptide specific antibodies 
to the ATM substrate KAP1. At least 300 cells were scored. Error bars indicate 
standard error, n=3. (D) Transfected cells were stained with propidium iodide 
and analyzed by flow cytometry.  
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lanes 2 and 4) and also causes an increase in CHK1 phosphorylation in untreated cells 
compared to cells transfected with non-targeting siRNA (compare lanes 1 and 3). This 
increased CHK1 phosphorylation in untreated cells following RPA70 silencing is 
presumably due to the stalling and collapse of replication forks, which activate the DNA 
damage response. Indeed, RPA70 silencing causes activation of ATM (295) and 
phosphorylation of its substrates, including KAP1 (Figure 4.1C). It also causes the 
activation of a G2 DNA damage checkpoint and accumulation of cells with 4N DNA 
content (Figure 4.1D). Co-transfection of a vector encoding wild-type RPA complements 
all of these phenotypes including the UV-induced CHK1 phosphorylation. Co-
transfection of the RPA R41E/R43E mutant also largely complements the spontaneous 
DNA damage defect, although there is evidence of a continued DNA damage response 
activation in a small percentage of successfully transfected cells (Figure 4.1C). However, 
the RPA70 R41E/R43E protein does not complement the defect in UV-induced CHK1 
phosphorylation in the endogenous RPA70-silenced cells (Figure 4.1B, compare lanes 4, 
6 and 8).     
These data combined with previously published results, indicate that mutations in 
ATRIP or RPA that abolish their primary binding surfaces do not yield identical 
phenotypes. The mutation in RPA causes a significant defect in CHK1 phosphorylation 
following UV radiation (Figure 4.1B), whereas the mutation in ATRIP did not (160). A 
possible explanation for this result is that the RPA mutation may interfere with binding to 
proteins other than ATRIP that are important for ATR signaling to CHK1. Indeed, this 
surface of RPA is known to interact with p53 (149), suggesting that it may mediate 
interactions with multiple proteins. We searched other checkpoint proteins for sequence 
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similarity to the RPA binding surfaces in ATRIP and p53 and found homologous regions 
in both MRE11 and RAD9 (Figure 4.2A).  To test whether these peptides were capable of 
binding to RPA, we employed the NMR-based chemical shift perturbation approach 
applied previously to investigate the interaction with ATRIP (151). A series of 15N-1H-
HSQC NMR spectra were acquired for uniformly 15N-labeled RPA70N protein as 
unlabeled ATRIP, RAD9, and MRE11 peptides were added into the solution. Significant 
chemical shift perturbations were observed upon the addition of increasing concentrations 
of all three peptides to RPA70N (Figure 4.2B to 4.2D). The chemical shift perturbations 
observed for the RAD9 and MRE11 peptides were remarkably similar to those of the 
ATRIP peptide (Figure 4.2B to 4.2D). Indeed, mapping of the perturbed residues onto the 
crystal structure of RPA70N reveals that all three peptides bind to the basic cleft of the 
OB-fold domain in similar manners (Figure 4.2E to 4.2G).  The small differences 
observed between the spectra of the three complexes are consistent with minor 
differences in the positioning of each peptide within the binding site, which reflect the 
differences in the sequence of each protein. 
 
The RAD9 C-terminal tail binds to RPA70N 
While MRE11 is known to function upstream of ATR at sites of double strand 
breaks, this does not appear to be the case after UV radiation or replication stress (234). 
RAD9, in contrast, is critical for ATR activation because of its role in recruiting the ATR 
activator TopBP1 (203, 206). The NMR data suggested that RAD9 uses a similar 
checkpoint recruitment domain (CRD) to bind to RPA70N.  Therefore, we tested whether  
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Figure 4.2. ATRIP, MRE11, and RAD9 interact with the same binding 
surface on RPA70N. (A) Sequence alignment of acidic peptides in RAD9, 
MRE11, ATRIP, and p53.  (B-D) The 15N-1H HSQC NMR spectra of 15N-labelled 
RPA70N were obtained in the absence (black) and presence (red) of ATRIP (B), 
RAD9 (C), or MRE11 (D) peptides. (E-G) The RPA70N residues perturbed upon 
addition of ATRIP (E), RAD9 (F), and MRE11 peptide (G) were mapped (in red) 
onto the crystal structure of RPA70N (PDB accession 2B3G). The NMR 
experiment was collaborated with Dr. Walter Chazin laboratory and was 
performed by Dr. Sivaraja Vaithiyalingam. 
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full-length RAD9 indeed binds RPA70N, and whether this interaction could explain the 
CHK1 phosphorylation defect we observed in RPA70 R41E/R43E-expressing cells. 
Purified GST-RPA70N binds RAD9 (Figure 4.3A). In contrast, neither GST nor 
the GST-RPA70N R41E/R43E mutant interacts with RAD9. We confirmed that both 
RAD9 and ATRIP compete for the same binding surface on RPA70N by doing a 
competition binding assay. When purified ATRIP1-217 containing its CRD was added to 
the pull-down experiment, it bound to RPA70N and blocked the ability of RPA70N to 
bind HA-RAD9 (Figure 4.3B).   
To determine whether the RPA binding surface on RAD9 contains the acidic C-
terminal peptide, mutations were engineered into the putative RAD9 CRD (Figure 4.4A).  
This RAD9 mutant (RAD9-crd) was epitope tagged and expressed either in HEK293 
cells or in rabbit reticulocyte lysates. The RAD9-crd mutant made in both systems 
migrates consistently faster than wild-type RAD9 on SDS-PAGE gels (Figure 4.4B). 
Wild-type RAD9 migrates as multiple bands due to its extensive phosphorylation (203, 
204). We initially considered whether the crd mutation might perturb RAD9 
phosphorylation.  However, both the DNA damage-induced S272 phosphorylation and 
damage-independent S387 phosphorylation are retained (Figure 4.4C).  Furthermore, the 
RAD9 and RAD9-crd proteins both form complexes with RAD1, RAD17, and TopBP1 
as expected (Figure 4.4D).  The interaction with TopBP1 is mediated by S387 
phosphorylation (203), while the interaction with RAD1 is mediated by the PCNA-
homology region within the rest of the protein (244). Thus, the RAD9-crd protein is 
stable, phosphorylated, and retains its known protein-protein interactions.  Its aberrant 
migration on SDS-PAGE gels is possibly due to an increase in its ability to bind SDS 
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Figure 4.3. RAD9 and ATRIP compete for the same binding 
surface on RPA70N. (A) Nuclear extracts from HEK293 cells 
expressing HA-RAD9 were incubated with GST, GST-RPA70N, or 
GST-RPA70N R41E/R43E proteins bound to glutathione beads. 
Proteins bound to the beads were eluted, separated by SDS-PAGE and 
immunoblotted with anti-HA antibody to detect RAD9 or stained with 
coomassie blue to detect GST proteins (CB). (B) BSA (1.6 nmols), 
purified ATRIP1-217 (0.8 nmols-1X or 1.6 nmols-2X), or purified 
ATRIP-crd (D58K/D59K) 1-217 (1.6 nmols) was added as indicated to 
nuclear extracts from HEK293 cells expressing HA-RAD9.  The 
nuclear extracts were incubated with 0.8 nmols of GST-RPA70N or 
GST proteins bound to glutathione beads. Proteins bound to the beads 
were eluted, separated by SDS-PAGE and immunoblotted with anti-HA 
antibody to detect RAD9 or stained with coomassie blue to detect GST 
proteins (CB).  
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Figure 4.4. The RAD9 checkpoint recruitment domain interacts with RPA70N. (A) Diagram of the 
RAD9-crd protein illustrating the positions of the engineered mutations and two of the phosphorylated 
residues.  (B) Wild-type HA-RAD9 (wt) or mutant HA-RAD9-crd (crd) was expressed in HEK293 cells 
or rabbit reticulocyte lysates. Total cell lysates (TCL) or the in vitro transcription/translation reactions 
(IVT) were resolved by SDS-PAGE and immunoblotted with HA antibodies. (C) Wild-type HA-RAD9 
or the RAD9-crd mutant was expressed in HEK293 cells. Cells were left untreated (-), or treated with 
HU (10 mM), UV (50 J/m2), or IR (20Gy).  One hour after treatment, cells were harvested, lysates were 
resolved by SDS-PAGE, and immunoblots were probed with antibodies to RAD9 P-S272, RAD9 P-
S387, or HA. Control is the lysate from untransfected cells. (D) Nuclear extracts from HEK293 cells 
expressing HA-RAD9 (wt), HA-RAD9-crd (crd), or untransfected (-) cells were incubated with anti-HA 
agarose beads. The immunoprecipitated proteins were separated on SDS-PAGE followed by 
immunoblotting with antibodies to RAD1, RAD17, TopBP1, and HA. The asterisk (*) marks the 
position of IgG heavy-chain background band.  (E and F) Nuclear extracts from HEK293 cells 
expressing HA-RAD9 (wt) or HA-RAD9-crd were incubated with GST-RPA70N or GST. Proteins 
bound to the beads were eluted, separated by SDS-PAGE, and detected by immunoblotting with anti-
HA antibody or staining with coomassie blue to detect GST-RPA70N and GST.  In (F) the extracts 
were treated with lambda phosphatase (PPase) in the absence or presence of sodium vanadate (VO4) as 
indicated prior to incubation with GST proteins. (G) HEK293 cells expressing HA-RAD9 (wt) or HA-
RAD9-crd (crd) were treated with IR 20Gy as indicated followed by 2 hours incubation. Chromatin 
lysates were prepared and incubated with anti-HA agarose beads. The immunoprecipitated proteins 
were separated on SDS-PAGE followed by immunoblotting with antibodies to HA and RPA70. 
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because of the replacement of three negative charges with three positively charged 
residues. We observed a similar change in SDS-PAGE mobility of ATRIP when we made 
mutations in the ATRIP CRD (data not shown) further supporting this interpretation. 
We next tested whether the RAD9-crd mutation impairs RPA binding.  In contrast 
to wild-type RAD9, the interaction between RAD9-crd and RPA70N is reduced while not 
abolished (Figure 4.4E and 4.4F). The lack of interaction is not due to a change in RAD9-
crd phosphorylation since the wild-type RAD9-RPA70N interaction is insensitive to 
phosphatase treatment (Figure 4.4F). Moreover, the RAD9-crd mutant has significantly 
reduced binding to endogenous RPA70 compared to wild-type RAD9 when measured by 
co-immunoprecipitation from solubilized chromatin fractions (Figure 4.4G). The residual 
co-immunoprecipitation may be due to an interaction between RAD9 and RPA32 (296). 
Combined with the NMR data, these results indicate that RAD9 binds to RPA70 through 
an acidic peptide within its C-terminal tail and the basic cleft of the RPA70N OB-fold 
domain, largely the same way as ATRIP binds RPA70 (151). 
 
The RAD9-RPA interaction regulates RAD9 localization 
Mutation of the ATRIP CRD prevents ATRIP from efficiently localizing to sites 
of DNA damage or replication stress (160). To determine whether the RAD9 CRD 
performs a similar function we created U2OS cells that express HA-RAD9 or HA-RAD9-
crd.  Both proteins were localized throughout the nucleus in untreated cells. Treatment 
with hydroxyurea (HU), UV, or ionizing radiation (IR) causes relocalization of both 
proteins to intra-nuclear foci; however, the RAD9-crd mutant consistently relocalized 
less efficiently (Figure 4.5A and 4.5B). To examine this more closely, the numbers of 
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foci in each cell were counted. This analysis revealed that following a low dose of IR, 
there were significantly fewer RAD9-crd nuclear foci than wild-type RAD9 foci (Figure 
4.5C). The RAD9 wild-type and crd mutants are expressed at equal levels (Figure 4.5D). 
Thus, although the RAD9 CRD-RPA70N interaction is not absolutely required to recruit 
RAD9 to sites of DNA damage, it does contribute to the efficiency of its localization.   
 
The RAD9-RPA interaction regulates ATR signaling 
We examined whether the RAD9-crd mutant could functionally complement 
RAD9-/- embryonic stem (ES) cells. CHK1 is not phosphorylated in response to DNA 
damage in RAD9-/- ES cells because of a defect in activating ATR (185). We created 
RAD9-/- ES cell clones stably expressing either wild-type RAD9 or the RAD9-crd mutant. 
Two cell clones expressing each protein were analyzed to ensure the results were not due 
to clonal selection. These cell clones expressed similar amounts of RAD9 protein (Figure 
4.6A). Immunofluorescence analysis indicated detectable expression of exogenous RAD9 
proteins in approximately 90% of all cells in all the four cell lines. While the wild-type 
RAD9 protein efficiently complemented the checkpoint signaling defect in the RAD9-/- 
cells, the RAD9-crd mutant was consistently less capable of supporting checkpoint 
signaling (Figure 4.6B and 4.6C). Following UV radiation, CHK1 phosphorylation in the 
RAD9-crd expressing cells was reduced by 33% compared to wild-type expressing cells 
(Figure 4.6B, compare lanes 4 and 6). Following HU exposure, the difference was 
approximately 60% (Figure 4.6C, compare lanes 9 and 10 and lanes 11 and 12). 
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Figure 4.5. The RAD9-RPA interaction promotes RAD9 localization to sites of 
DNA damage. (A and B) U2OS cells stably expressing HA-RAD9 or HA-RAD9-crd 
were left untreated (NT) or treated with HU (10 mM) for 4 hours, UV (50 J/m2) 
followed by one hour recovery, or IR (10Gy) followed by 6 hours recovery. Fixed 
cells were stained with anti-HA antibody and FITC–conjugated secondary antibody. 
(A) Representative images are shown. (B) Cells were scored for RAD9 localization to 
DNA damage foci. 300 cells were scored per experiment.  Error bars indicate standard 
error (n=3). P values were calculated using an unpaired, two-tailed t-test. (C) HA-
RAD9 or HA-RAD9-crd expressing U2OS cells were treated with low dose IR (1Gy) 
or left untreated followed by 6 hours incubation. The number of RAD9 foci in each 
cell was scored. (D) The expression level of HA-RAD9 and HA-RAD9-crd in the 
U2OS cells was analyzed by immunoblotting with anti-HA or anti-GAPDH antibody.  
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Figure 4.6. The RAD9-RPA interaction regulates DNA damage and 
replication stress responses. (A) Protein expression levels in two 
independent clones of RAD9-/- embryonic stem cells stably expressing HA-
RAD9 or HA-RAD9-crd were analyzed by immunoblotting total cell 
lysates. (B and C) RAD9+/+ and RAD9-/- cells complemented with vector (-
/-), HA-RAD9 (wt1 and wt2), or HA-RAD9-crd (crd1 and crd2) were 
treated with UV (50J/m2), HU (10mM), or left untreated as indicated. 
Following incubation for one hour, lysates were prepared, resolved by 
SDS-PAGE and immunoblotted with antibodies to CHK1 P-S345 or total 
CHK1. The phospho-CHK1 and CHK1 levels were quantitated with NIH 
Image software. The numbers are the ratio of phospho-CHK1 to CHK1 
normalized to the sample from cells complemented with vector (-/-) after 
damage. (D) ES cell clones were treated with HU (10 mM for 12 hours) or 
(E) UV (10 J/m2), and grown for 7 days prior to staining and scoring 
surviving colonies. Percent viability was calculated as compared to 
untreated cell populations.  Error bars indicate standard error (n=3). P 
values were calculated using an unpaired, two-tailed t-test.  
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The defective DNA damage response activation in the RAD9-crd expressing cells 
correlated with a hyper-sensitivity of these cells to HU and UV compared to wild-type 
RAD9 expressing cells (Figure 4.6D and 4.6E).  In both cases, the RAD9-crd expressing 
cells exhibited an intermediate sensitivity to these agents compared to the RAD9-/- cells 
expressing wild-type RAD9 or transfected with an empty vector. 
 
Discussion 
RPA functions as a single-stranded DNA binding protein in most nucleic acid 
metabolic processes.  Its interactions with other proteins facilitate replication, repair, and 
checkpoint signaling (36, 156). RPA-ssDNA is thought to be the common intermediate in 
activating the ATR checkpoint pathway in response to a diversity of genome integrity 
challenges (133). ATR activation requires co-localization of the ATR-ATRIP and 9-1-1 
complexes. RPA-ssDNA and a 5' primer-template junction are critical ligands to recruit 
these protein complexes (137, 159-161, 190, 196). We now show that a common protein-
interaction surface on the N-terminal OB-fold domain of RPA70 binds to both ATRIP 
and RAD9.  Both ATRIP and RAD9 contain an acidic patch that is predicted to fold into 
an alpha-helical structure capable of binding into the basic cleft of RPA70N.  Given its 
similarity to the ATRIP checkpoint recruitment domain (CRD) we have named this 
region the RAD9 CRD. 
Mutations in ATRIP, RAD9, or RPA that disrupt the ATRIP-RPA70 or RAD9-
RPA70 interactions cause defects in checkpoint protein localization [this study and 
references (151, 160)]. Both the RAD9-crd and the RPA70 R41E/R43E mutant proteins 
cause similar deficiencies in ATR-dependent signaling to CHK1. The ATRIP-crd mutant 
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does not cause a detectable ATR signaling defect, at least as assayed by RNAi 
complementation analysis (160). However, it is possible that there are other contact 
points between RPA and ATRIP (169), and there are RPA-independent means of 
localizing the ATR-ATRIP complex (174, 268, 297). RPA frequently binds proteins 
using multiple subunits (298), and both RPA70 and RPA32 have been implicated in 
RAD9 interactions (296).   
Our data on the role of human RPA in checkpoint signaling are consistent with 
the function of S. cerevisiae RPA (Rfa).  The rfa1-t11 mutant in budding yeast supports 
DNA replication but is compromised in DNA damage responses including a defect in 
loading the yeast 9-1-1 complex (157, 158, 211, 299). This mutation is a charge reversal 
in Rfa1 at residue K45 (analogous to the R41 site of human RPA70).  Our data are also 
consistent with a recent analysis of a human RPA70 R41E/Y42F mutant which was 
reported to cause a G2/M checkpoint defect without causing a defect in ssDNA binding 
or DNA replication (300). 
The RPA70N OB-fold domain is attached to the rest of RPA70 through a flexible 
linker (301). This flexibility may be important to allow RPA to recruit different 
checkpoint proteins and position them correctly for ATR kinase activation.  In addition, 
since RPA binds ssDNA with a defined 5'-3' polarity (143, 144), the RPA70N OB-fold is 
positioned near the 5'-end of a primer-template junction (Figure 4.7). This position places 
it in an ideal location to mediate the 5'-junction specificity of 9-1-1 complex loading (159, 
161). The RPA-RAD9 interaction may also help position the RAD9 tail such that it can 
present TopBP1 to ATR-ATRIP complexes in an optimal orientation. 
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Figure 4.7. Simplified model of the RPA protein and DNA 
interactions that promote ATR signaling.  RPA is a heterotrimer 
of three subunits, RPA70, RPA32, and RPA14 that contain six OB-
folds.  Four of these OB-fold domains can bind single-stranded 
DNA in a specific orientation such that the amino-terminal RPA70 
OB-fold (70N) is positioned near the 5' primer-template junction.  
The RPA70N OB-fold binds checkpoint proteins including ATRIP 
and RAD9.  These interactions help to concentrate ATR-ATRIP 
and 9-1-1-TopBP1 complexes to promote TopBP1 activation of 
ATR.  Many additional protein-protein and protein-nucleic acid 
interactions also participate but are not shown in this simplified 
diagram. 
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Since ATRIP and RAD9 bind to the same surface of RPA, they are unlikely to be 
capable of binding at the same time. Indeed, ATRIP and RAD9 compete for binding to 
RPA70N (Figure 4.3B). This raises an interesting question of what is the timing of these 
interactions. Competitive binding to the same RPA surface may indicate that at least two 
molecules of RPA need to be present to efficiently activate ATR. Such a scenario would 
ensure that the ATR checkpoint is only activated when longer stretches of ssDNA are 
available.  This hypothesis is consistent with the ssDNA length dependency for ATR 
activation which was observed using defined DNA templates to activate ATR in X. laevis 
egg extracts (140). It is also possible that another protein retains the ATR-ATRIP or 9-1-
1 complexes at the site of DNA damage or replication stress. Once loaded, the 9-1-1 
checkpoint clamp is topologically linked to the DNA.  The RPA interaction may serve to 
decrease its ability to slide away from the ssDNA gap.   
While we did not pursue our observation that MRE11 contains a peptide that 
binds RPA70N (Figure 4.2), a recent publication mapped an RPA binding surface on 
MRE11 to amino acids 521-569 (302). Notably, this region contains the acidic peptide 
we used in the NMR experiment.  Furthermore, double mutation of D543 and D544 in 
MRE11 abolished the RPA interaction, impaired localization of MRE11 to replication 
centers, and caused a defect in the S-phase checkpoint (302).  Our data suggest that this 
mutant disrupts an MRE11 CRD that interacts with the basic cleft of RPA70N.  These 
data further support our conclusions that RPA70N provides a common checkpoint protein 
binding surface, and RPA-ssDNA is a signal for recruitment of multiple DNA damage 
response proteins. 
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The ATR signaling pathway is a potential target for cancer therapy (303, 304). 
ATR signaling inhibitors are expected to sensitize cells to DNA damaging agents.  
Cancer cells are also known to have higher levels of replicative stress than adjacent 
normal cells (88, 89). Thus, cancer cells may be more dependent on replication stress 
responses than normal cells to complete replication and retain viability. Thus, targeting 
the replication stress response could be a useful therapy.  Our results suggest the basic 
cleft in RPA70N may be a useful target for the development of a protein-protein 
interaction inhibitor.   Inhibiting RPA from binding multiple checkpoint proteins (at least 
ATRIP, RAD9, MRE11 and p53) should significantly impair the replication stress 
response.  We are currently investigating whether our understanding of the structural 
basis for binding specificity can enable development of a selective DNA damage 
checkpoint inhibitor that suppresses the DNA damage response without eliminating the 
essential replication function of RPA.   
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CHAPTER V 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Conclusions 
Establishing a model system with a site-specific stalled replication fork 
I established an episome-based system in which a replication fork is stalled at a 
defined site (Chapter II). In this system, the inter-strand cross-link is achieved on DNA at 
a specific site, and the replication forks initiated from the SV40 origin can be paused at 
the cross-linked site in COS-cells. Also intra-strand cross-links on the leading strand and 
the lagging strand are achieved separately at the specific site. When added into Xenopus 
egg extracts, the intra-strand cross-link on DNA induces a higher level of Chk1 
phosphorylation than the inter-strand cross-link. This suggests that the combination of 
cross-linked episomes and Xenopus egg extracts is a useful model system for studying 
protein recruitment to a stalled replication fork. 
 
ATRIP S224 phosphorylation by Cdk2 is required for G2-M checkpoint maintenance 
ATRIP interacts with ATR and is an essential partner for ATR function (163). 
ATR functions to delay cells from entering mitosis when cells are challenged by DNA 
damage (133). Phosphorylation of ATRIP S224 correlates with S phase in the cell cycle 
and is not induced by DNA damage or replication stress (Chapter III). Instead, 
phosphorylation of ATRIP on S224 is regulated by Cdk2. Phosphorylation of ATRIP 
S224 is inhibited when cells are treated with a Cdk2 inhibitor. ATRIP S224 is a substrate 
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of Cdk2-cyclin A in vitro. The mutation of ATRIP S224 to alanine compromises G2-M 
checkpoint maintenance induced by UV and IR. Thus, in addition to being a target for 
ATR-dependent checkpoint responses, Cdk2 is also a direct regulator of the ATR-ATRIP 
checkpoint kinase complex.  
 
CINP regulates ATR signaling 
We identified CINP as a novel ATRIP interacting protein (Chapter III). CINP 
interacts with the first coiled-coil domain of ATRIP. Depletion of CINP compromises 
phosphorylation of Chk1 on S345 and S317 when cells are treated with UV or IR. 
Furthermore, depletion of CINP compromises the G2-M checkpoint maintenance induced 
by UV or IR. Depletion of CINP also causes a decreased level of ATRIP phosphorylation 
on S224. Therefore, ATR signaling is regulated by CINP partially through regulating 
phosphorylation of ATRIP S224. 
 
RPA70N is a checkpoint signaling module 
The N terminal OB fold domain of RPA70 (RPA70N) forms a pocket structure 
with multiple positively charged residues on its surface (149, 151). The acidic regions of 
P53 and ATRIP interact with RPA70N (252). Both Mre11 and Rad9 contain homologous 
regions of the acidic regions on P53 and ATRIP. We determined that the acidic regions of 
ATRIP, Mre11, and Rad9 interact with RPA70N in similar manners (Chapter IV). A 
double charge reversal mutation of RPA70N (R41E/R43E) abolishes RPA70N 
interaction with ATRIP and Rad9. The RPA70 R41E/R43E mutant causes a defect in 
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Chk1 phosphorylation following UV radiation. Thus, the RPA70N domain is a 
checkpoint signaling module.  
 
Rad9-RPA70N interaction regulates ATR signaling 
The acidic region on the C-terminal tail of Rad9 interacts with the RPA70N 
domain. The Rad9-crd mutant disrupts Rad9 interaction with RPA70N while its 
interactions with Rad17 and TopBP1 remain (Chapter IV). The Rad9-crd mutant exhibits 
less efficient foci formation after DNA damage and replication stress compared to wild 
type Rad9. Cells expressing the Rad9-crd mutant exhibit compromised Chk1 
phosphorylation after DNA damage and replication stress treatment. Furthermore, cells 
expressing the Rad9-crd mutant are hypersensitive to DNA damage and replication stress 
treatment. Thus, ATR signaling is regulated by an RPA70N interaction with Rad9. 
 
Further Discussion and Future Directions 
Stabilizing a stalled replication fork 
How are stalled replication forks stabilized in cells? Evidence in yeast suggests 
that the ATR signaling pathway plays a role for cells to recover from replication stress or 
MMS treatment (248, 249). We hypothesized that the ATR-mediated checkpoint 
functions in stabilizing stalled forks in mammalian cells as in yeast and proposed to study 
checkpoint protein recruitment to stalled forks by CHIP. Establishing a stalled fork on 
DNA at a defined site is an initial step to test this hypothesis. The episome-based system, 
which can replicate in cells and Xenopus egg extracts, allows us to detect protein 
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recruitment to a stalled fork by CHIP. Therefore, the next step is to detect proteins 
involved in ATR signaling on the stalled fork by CHIP. 
The attempt to detect three proteins, ATRIP, ATR, and RPA on the stalled fork by 
CHIP was unsuccessful when cross-linked episomes were transfected into cells. 
Checkpoint activation upon transfection of cross-linked episomes will encourage our 
hypothesis. However, Chk1 phosphorylation was not detectable when the cross-linked 
episomes were transfected into mammalian cells. Although it is not clear whether the 
intra-strand cross-link can stall the fork progression in cells, it does induce detectable 
Chk1 phosphorylation in the egg extract. Therefore, the combination of cross-linked 
episomes and Xenopus egg extracts is the model system we should use to detect 
checkpoint protein recruitments to the stalled replication fork by CHIP. 
CHIP requires a high quality of antibody to enrich for the proteins to be detected. 
The antibodies I used here may not be suitable for CHIP. Different antibodies may yield 
positive results. Alternatively, we can perform streptavidin pull-down as described in 
Chapter II to detect RPA, ATRIP, and ATR in the egg extract system after cross-linked 
episome is added.  
Why does the intra-strand cross-link induce Chk1 phosphorylation in the egg 
extract but not in mammalian cells? One possible reason is that the egg extract provides a 
robust replication environment. In cells, the intra-strand cross-link could be bypassed or 
repaired before the replisome encounters it. At earlier time points, episome replication 
has not been maximally initiated. If this is the case, using cells deficient for translesion 
synthesis and DNA repair may yield Chk1 phosphorylation upon addition of the cross-
linked episomes. Consistently, the intra-strand cross-link induces Chk1 phosphorylation 
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at 30 minutes when added into the egg extract, and the level of Chk1 phosphorylation 
decreases at 45 minutes and 60 minutes. Depletion of proteins for translesion synthesis 
and DNA repair from the egg extract will extend the duration of Chk1 phosphorylation. 
Why does the intra-strand cross-linked episome induce Chk1 phosphorylation 
while the inter-strand cross-linked episome does not? It has been shown that inhibition of 
DNA helicase activity suppresses ATR signaling in response to replication stress (139). 
We propose that the inter-strand cross-link stalls DNA helicases and polymerases while 
the intra-strand cross-link only stalls the DNA polymerases (Figure 5.1). Therefore, the 
intra-strand cross-link generates the ATR activation structure by functional uncoupling 
DNA helicases and polymerases. Localization of DNA helicases and polymerases on 
stalled forks induced by different cross-links can be detected by CHIP. 
How do cells repair different lesions on DNA? Inter-strand cross-links and cross-
links on the leading strand and lagging strand can be generated separately in the episome-
based system as described in Chapter II. Products of DNA repair can be examined by 
PCR followed by DNA sequencing. Moreover, whether DNA replication alters the repair 
pathway and efficiency can be determined by deletion of the episome origins.  
 
How phosphorylation of ATRIP regulates ATR signaling 
ATRIP is phosphorylated on S68 and S72 by ATR upon DNA damage treatment 
(173). The functional significance of ATRIP phosphorylation on S68 and S72 is unclear 
(140). S68 and S72 sites fall in the region of the RPA interaction domain of ATRIP. They 
may contribute to the interaction between ATRIP and the basic cleft of RPA70N domain. 
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Figure 5.1. Illustration of DNA helicase and polymerase localization on the 
stalled fork. (A) A replication fork is stalled by inter-strand cross-link. Both 
DNA helicase and polymerase are stalled before the cross-link site. (B) A 
replication fork is stalled by intra-strand cross-link on the leading strand (the 
lagging strand polymerase is not shown for simplicity). DNA polymerase is 
stalled before the cross-link site, but the helicase is not. Although the uncoupling 
of polymerase and helicase is drawn here, DNA polymerase may not physically 
uncouple from the helicase. 
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An ATRIP phosphor peptide with S68 and S72 phosphorylation can be used to detect its 
direct interaction with the purified RPA70N protein in vitro. 
Phosphorylation of ATRIP on S224 and S239 is required for G2-M checkpoint 
maintenance (176). ATRIP S224 is a substrate of Cdk2. The kinase responsible for 
phosphorylation of ATRIP S239 has not been determined. With a panel of specific kinase 
inhibitors, we can identify the kinase responsible for ATRIP S239 phosphorylation. It is 
unclear how phosphorylation of ATRIP S224 regulates the activation of ATR-ATRIP 
checkpoint responses. Phosphorylation of ATRIP S224 is not required for ATRIP binding 
to RPA, localization to sites of DNA damage, or binding to ATR. In addition, ATR-
ATRIP complexes containing the ATRIP S224A mutant have similar kinase activities in 
vitro as wild type complexes in the presence and absence of TopBP1. One possibility is 
phosphorylation of S224 creates a binding site for another protein involved in the 
maintenance of G2-M checkpoint. 
An ATRIP peptide containing phosphorylation of S239 interacts with BRCT 
repeats of BRCA-1 (175). This suggests that S239 phosphorylation dependent ATRIP 
interaction with BRCA-1 may be a mechanism of ATR activation. The BRCT domains 
often function in tandem as phospho-protein binding domains (282). ATRIP S224 
phosphorylation may also contribute to ATRIP interaction with BRCA-1.  
 
How CINP regulates ATR signaling 
Depletion of CINP decreases the phosphorylation level of ATRIP on S224. 
Therefore, ATRIP S224 phosphorylation may be one of the mechanisms by which CINP 
regulates ATR signaling. CINP was identified as a Cdk2 interacting protein by a yeast 
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two-hybrid assay (275). Because phosphorylation of ATRIP S224 is regulated by Cdk2-
cyclin A directly, CINP may function as a bridge between Cdk2 and ATRIP. This can be 
tested by examining ATRIP interaction with Cdk2 in the absence and presence of CINP. 
Also it is possible that CINP plays a role to protect the phosphorylation of ATRIP S224 
from phosphatases. In this case, the phosphatase remains to be identified. 
Depletion of CINP causes comparable defects as ATRIP depletion in G2-M 
checkpoint maintenance. However, depletion of CINP only decreases ATRIP S224 
phosphorylation about 45%. This suggests that CINP also regulates ATR signaling 
through other mechanisms in addition to ATRIP S224 phosphorylation. Identifying CINP 
interacting proteins will reveal other mechanisms by which CINP regulates ATR 
signaling. 
CINP is identified as a novel ATRIP interacting protein and is required for ATR 
signaling. Whether CINP interaction with ATRIP regulates ATR activation remains to be 
determined. CINP has a predicted coiled-coil domain. Coiled-coil domains often mediate 
protein-protein interaction (283). Moreover, CINP interacts with the first coiled-coil 
domain of ATRIP. It is likely that the coiled-coil domain of CINP mediates CINP 
interaction with ATRIP. CINP interaction with ATRIP can be disrupted by a CINP 
mutant that lacks the coiled-coil domain. Functional characterization for this CINP 
mutant will reveal whether CINP interaction with ATRIP regulates ATR signaling. 
 
The roles of RPA70N in ATR signaling 
RPA functions as an ss-DNA binding protein in most nucleic acid metabolic 
processes (36). Its interactions with other proteins facilitate DNA replication, DNA repair, 
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and checkpoint signaling (36, 156). ATR activation requires co-localization of the ATR-
ATRIP and 9-1-1 complexes. RPA-ss-DNA and a 5′-DNA junction are critical for 
recruiting these proteins (137, 159-161, 190, 196). Localization of the ATR-ATRIP 
complex to sites of DNA damage is primarily regulated by the interaction of RPA70N 
with the N terminal region of ATRIP (137, 151, 160). A conserved checkpoint 
recruitment domain (CRD) in ATRIP orthologs is critical for ATRIP localization to sites 
of DNA damage in humans and yeast [Figure 5.2A and reference (151)]. Here we 
identified a similar acidic region on Rad9 and Mre11 (Figure 5.2B and 5.2C). 
All the crd mutants of ATRIP, Mre11, and Rad9 exhibit dramatically reduced interaction 
with RPA70N [this study and  references (151, 160, 302)]. Although the ATRIP-crd and 
Mre11-crd mutants exhibit strong defects in foci formation in response to DNA damage 
(151, 160, 302), the Rad9-crd mutant only causes a mild defect in Rad9 localization 
(Chapter IV). This suggests that Rad9 can be recruited to sites of DNA damage by 
alternative mechanisms. Consistent with this hypothesis, both RPA70 and RPA32 have 
been implicated in Rad9 interaction (296). The approach of immunofluorescence 
microscopy can not differentiate between loading and retention of proteins. Compared to 
ATRIP and Mre11, the 9-1-1 checkpoint clamp forms a ring structure to circle DNA and 
is topologically linked to the DNA once loaded. Therefore, the retention of Rad9 at sites 
of DNA damage may not require the interaction of Rad9 and RPA70N while the retention 
of ATRIP and Mre11 at sites of DNA damage requires RPA70N.  
The Rad9-crd mutant exhibits defective ATR signaling (chapter IV). The Mre11-
crd mutant causes a defect in S-phase checkpoint (302). However, the ATRIP-crd mutant 
exhibits wild type ATR signaling (160). This could be due to the different approaches 
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   Human ATRIP      1 DFTADDLEELDTLAS 
   Xenopus ATRIP    1 DFTADDLEEIDILAS 
   Mouse ATRIP      1 EFTADDLEELDILAS 
 
 
   Human Rad9     297 DFANDDIDSYMIAME 
   Mouse Rad9     297 DFTSDDIDCYMIAME 
   Xenopus Rad9   288 DFLGDDID-YMIAME 
 
 
   Human Mre11    539 AFSADDLMSIDLAEQ 
   Mouse Mre11    540 AFSAEDLS-FDTSEQ 
   Xenopus Mre11  542 SDEDDDALLRKVSLS 
 
Figure 5.2. Evolutionarily conserved acidic regions on ATRIP, Rad9, 
and Mre11. (A) Sequence alignment of the conserved acidic region in 
the N terminal of ATRIP orthologues. (B) Sequence alignment of the 
acidic region in Rad9 orthologues. (C) Sequence alignment of the acidic 
region in Mre11 orthologues. 
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used to study functional complementation. The Rad9-crd and Mre11-crd mutants were 
used to reconstitute Rad9 and Mre11 deficient cells respectively while the ATRIP-crd 
mutant was examined by siRNA complementation. Consistent with this possibility, the 
Ddc2ATRIP-crd mutant causes a defect in Rad53 phosphorylation after DNA damage (151). 
It is also possible that ATRIP-crd can be loaded to sites of DNA damage by other 
mechanisms although the retention of ATRIP is defective (169, 174, 268, 297), and this 
alternative loading of ATRIP-crd is efficient as wild type ATRIP to activate ATR. 
Since ATRIP and Rad9 bind to the same surface of RPA70, they are unlikely to 
be capable of binding at the same time. A purified ATRIP-CRD fragment competes with 
Rad9 for the RPA70N domain (Chapter IV). What is the timing of these interactions 
when an ATR activation structure is generated? Competitive binding to the same RPA 
surface may indicate that at least two molecules of RPA need to be present to efficiently 
activate ATR. Such a scenario would ensure that the ATR checkpoint is only activated 
when long stretches of ssDNA are available. This hypothesis is consistent with the 
ssDNA length dependency of ATR activation which was observed using defined DNA 
templates to activate ATR in Xenopus egg extracts (140). It is also possible that another 
protein retains the ATR-ATRIP or 9-1-1 complexes at the site of DNA damage. RPA 
binds to ssDNA with a defined 5′→3′ polarity (190). Therefore, the RPA70N faces the 5′-
DNA junction at the ATR activation structure. The 9-1-1 checkpoint clamp is 
preferentially loaded to a 5′-DNA junction and can slide on DNA once loaded (159, 161). 
These discoveries suggest that the RPA70N-Rad9 interaction may serve to decrease the 
ability of Rad9 to slide away from the ssDNA gap (Figure 5.3). Reconstitution of the  
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Figure 5.3. RPA70N retains 9-1-1 complex at the 5'-DNA junction from sliding 
away.    
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Rad9-crd-Hus1-Rad1 complex loading to 5'-DNA junction in vitro in the presence of 
Rad17-RFC complex and RPA will directly test this hypothesis. 
Our data show that the RPA70 R41E/R43E mutant causes a defect in ATR 
signaling without causing a defect in DNA replication. This is consistent with the 
analysis of the RPA70 R41E/Y42F mutant, which exhibits a G2-M checkpoint defect 
without a defect in ss-DNA binding or DNA replication (300). Our data on the role of 
RPA70N in checkpoint signaling is also consistent with the function of Rfa1RPA70 in S. 
cerevisiae. 
The 9-1-1 complex recruits TopBP1 to stalled forks through Rad9 interaction with 
TopBP1 (217, 218). TopBP1 enhances ATR kinase activity (159). Therefore, TopBP1 is 
concentrated at stalled replication forks by the 9-1-1 complex to stimulate the kinase 
activity of ATR. Although Rad9 interaction with RPA70N regulates ATR signaling in 
vivo, this regulation is not essential for ATR signaling because Chk1 phosphorylation is 
reduced but not abolished with the Rad9-crd mutant (Chapter IV). Consistently, this 
regulation can be bypassed by fusing the ATR activation domain of TopBP1  to PCNA or 
9-1-1 complex lacking the C-tail of Rad9 for ATR signaling (203). 
 
RPA70N functions in other processes 
RPA70N regulates Mre11 localization to replication centers in the absence of 
exogenous DNA damage or replication stress (302). This suggests that RPA70N may 
have some other roles in addition to checkpoint signaling. RPA70 interacts with many 
proteins for DNA replication, checkpoint signaling, and DNA repair (36, 156). Although 
an acidic region with a predicted alpha-helical structure is a common feature of CRD 
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domains on Rad9, ATRIP, Mre11, and p53, it is difficult to predict what other proteins 
may interact with RPA70N by sequence. GST-RPA70N can be used as bait to enrich 
candidate proteins on beads by a pull-down method and the RPA70 R41E/R43E mutant 
will be a good negative control. Mass spectrometry can be performed to identify the 
enriched candidate proteins.  
 
RPA70N is a potential target for cancer therapy 
Cancer cells are known to have higher levels of replicative stress than adjacent 
normal cells (88, 89). The ATR signaling pathway is the primary cellular response to 
replication stress (133). Thus, cancer cells may be more dependent on ATR signaling 
than normal cells to survive. Chk1, Claspin, ATR-ATRIP, and 9-1-1 complexes function 
in ATR signaling and also are essential for cellular viability (163, 185, 231). This 
suggests that ATR signaling is essential for viability. Eliminating all ATR signaling 
would be cytotoxic to normal and malignant cells. Pharmacological agents usually yield 
partial loss of function phenotypes. Thus, partial inhibition of ATR signaling could be a 
useful therapy to selectively kill cancer cells.  
Traditionally, targeting protein kinases has relied on the development of ATP 
analogs that act as competitive inhibitors for the binding of ATP to the catalytic domain 
of kinases. This strategy raises an issue about the specificity of the inhibitors to kinases. 
For example, the ATR inhibitors, caffeine and wortmannin, are not specific for ATR. The 
Chk1 inhibitor, UCN-01 is not specific for Chk1 (305).  
Our data suggests that the basic cleft of RPA70N binds multiple checkpoint 
proteins, ATRIP, Rad9, Mre11, and p53. Mutation and deletion of RPA70N does not 
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cause a defect in DNA replication [Chapter IV and reference (300)]. ATRIP, Rad9, and 
Mre11 all function in response to replication stress. Inhibiting RPA70N from binding 
these proteins should significantly impair the replication stress response, which will 
decrease the viability of cancer cells. The specificity of this inhibition is expected to be 
better than kinase inhibitors. We currently are investigating whether our understanding of 
the structural basis for binding specificity can enable the development of a selective DNA 
damage checkpoint inhibitor that suppresses the DNA damage response. 
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